<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA Network Open</journal-title></journal-title-group><issn pub-type="epub">2574-3805</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12475942</article-id><article-id pub-id-type="pmcid-ver">PMC12475942.1</article-id><article-id pub-id-type="pmcaid">12475942</article-id><article-id pub-id-type="pmcaiid">12475942</article-id><article-id pub-id-type="pmid">41004145</article-id><article-id pub-id-type="doi">10.1001/jamanetworkopen.2025.34275</article-id><article-id pub-id-type="publisher-id">zoi250960</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-only"><subject>Online Only</subject></subj-group><subj-group subj-group-type="subject-area"><subject>Neurology</subject></subj-group></article-categories><title-group><article-title>Telestroke and Timely Treatment and Outcomes in Patients With Acute Ischemic Stroke</article-title><alt-title alt-title-type="headline">Telestroke and Timely Treatment and Outcomes for Acute Ischemic Stroke</alt-title><alt-title alt-title-type="running-head">Telestroke and Timely Treatment and Outcomes for Acute Ischemic Stroke</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Stamm</surname><given-names initials="B">Brian</given-names></name><degrees>MD</degrees><degrees>MSc</degrees><xref rid="zoi250960aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="zoi250960aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi250960aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="zoi250960aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Whitney</surname><given-names initials="RT">Rachael T.</given-names></name><degrees>PhD</degrees><xref rid="zoi250960aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Royan</surname><given-names initials="R">Regina</given-names></name><degrees>MD</degrees><degrees>MPH</degrees><xref rid="zoi250960aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="zoi250960aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi250960aff6" ref-type="aff">
<sup>6</sup>
</xref><xref rid="zoi250960aff7" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ibrahim</surname><given-names initials="G">Ghada</given-names></name><degrees>MS</degrees><xref rid="zoi250960aff8" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nickles</surname><given-names initials="AV">Adrienne V.</given-names></name><degrees>MPH</degrees><xref rid="zoi250960aff8" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ferber</surname><given-names initials="RA">Rebecca A.</given-names></name><degrees>MPH</degrees><xref rid="zoi250960aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ye</surname><given-names initials="W">Wen</given-names></name><degrees>PhD</degrees><xref rid="zoi250960aff9" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hsu</surname><given-names initials="WL">Wan-Ling</given-names></name><degrees>PhD</degrees><xref rid="zoi250960aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chhabra</surname><given-names initials="N">Nikita</given-names></name><degrees>DO</degrees><xref rid="zoi250960aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hayward</surname><given-names initials="RA">Rodney A.</given-names></name><degrees>MD</degrees><xref rid="zoi250960aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi250960aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="zoi250960aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>McDermott</surname><given-names initials="M">Mollie</given-names></name><degrees>MD</degrees><degrees>MS</degrees><xref rid="zoi250960aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Scott</surname><given-names initials="PA">Phillip A.</given-names></name><degrees>MD</degrees><xref rid="zoi250960aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sheth</surname><given-names initials="KN">Kevin N.</given-names></name><degrees>MD</degrees><xref rid="zoi250960aff10" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Reeves</surname><given-names initials="MJ">Mathew J.</given-names></name><degrees>BVSc</degrees><degrees>PhD</degrees><xref rid="zoi250960aff11" ref-type="aff">
<sup>11</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Levine</surname><given-names initials="DA">Deborah A.</given-names></name><degrees>MD</degrees><degrees>MPH</degrees><xref rid="zoi250960aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="zoi250960aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi250960aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="zoi250960aff1"><label>1</label>Department of Neurology, University of Michigan, Ann Arbor</aff><aff id="zoi250960aff2"><label>2</label>Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor</aff><aff id="zoi250960aff3"><label>3</label>VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan</aff><aff id="zoi250960aff4"><label>4</label>Geriatric Research Education and Clinical Center, VA Ann Arbor Healthcare System, Ann Arbor, Michigan</aff><aff id="zoi250960aff5"><label>5</label>Department of Internal Medicine, University of Michigan, Ann Arbor</aff><aff id="zoi250960aff6"><label>6</label>Department of Emergency Medicine, University of Michigan, Ann Arbor</aff><aff id="zoi250960aff7"><label>7</label>Assistant Editor, <italic toggle="yes">JAMA Network Open</italic></aff><aff id="zoi250960aff8"><label>8</label>Michigan Department of Health and Human Services, Lansing</aff><aff id="zoi250960aff9"><label>9</label>Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor</aff><aff id="zoi250960aff10"><label>10</label>Center for Brain and Mind Health, Departments of Neurology and Neurosurgery, Yale School of Medicine, Yale University, New Haven, Connecticut</aff><aff id="zoi250960aff11"><label>11</label>Department of Epidemiology and Biostatistics, Michigan State University, East Lansing</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> July 19, 2025.</p><p content-type="published-online"><bold>Published:</bold> September 26, 2025. doi:<uri content-type="doi">10.1001/jamanetworkopen.2025.34275</uri></p><p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. &#169; 2025 Stamm B et al. <italic toggle="yes">JAMA Network Open</italic>.</p><corresp id="zoi250960cor1"><bold>Corresponding Author:</bold> Brian Stamm, MD, MSc, Department of Neurology, Institute for Health Care Policy and Innovation, University of Michigan, 2800 Plymouth Rd, Bldg 16, Room 471C, Ann Arbor, MI 48109 (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bstamm@med.umich.edu">bstamm@med.umich.edu</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Stamm and Whitney had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic toggle="yes">Concept and design:</italic> Stamm, Royan, Nickles, Chhabra, Levine.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> Stamm, Whitney, Royan, Ibrahim, Nickles, Ferber, Ye, Hsu, Hayward, McDermott, Scott, Sheth, Reeves, Levine.</p><p><italic toggle="yes">Drafting of the manuscript:</italic> Stamm, Whitney, Royan, Chhabra.</p><p><italic toggle="yes">Critical review of the manuscript for important intellectual content:</italic> All authors.</p><p><italic toggle="yes">Statistical analysis:</italic> Stamm, Whitney, Ye, Hsu, Hayward.</p><p><italic toggle="yes">Obtained funding:</italic> Stamm.</p><p><italic toggle="yes">Administrative, technical, or material support:</italic> Stamm, Royan, Ibrahim, Nickles, Ferber, McDermott, Scott, Reeves, Levine.</p><p><italic toggle="yes">Supervision:</italic> Stamm, Nickles, McDermott, Scott, Sheth.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Royan reported receiving a grant from the National Institute of Neurological Disorders and Stroke (K12NS137516) during the conduct of the study. Ms Ferber reported receiving grants from the National Institutes of Health (NIH) outside the submitted work. Dr Scott reported receiving grants from NIH during the conduct of the study. Dr Sheth reported receiving grants from NIH during the conduct of the study; grants from Hyperfine, Genentech, and the American Heart Association; and personal fees from Astrocyte, Bexorg, and BrainQ outside the submitted work; and an issued patent for Alva. Dr Levine reported receiving grants from NIH and consulting fees on NIH grants from Tufts University and Northwestern University outside the submitted work. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> This work was supported, in part, by the Michigan Department of Health and Human Services, as well as through grant 1NU58DP007883-01-00 from the Centers for Disease Control and Prevention. This work received funding from the Timely Topics in Telehealth/e-Health Research Seed Grant from the Institute for Healthcare Policy and Innovation at the University of Michigan.</p><p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p><bold>Disclaimer:</bold> The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of Centers for Disease Control and Prevention. Dr Royan is an Assistant Editor at <italic toggle="yes">JAMA Network Open</italic>. She was not involved in any editorial decisions related to this manuscript.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-ZOI250960-1-s" ref-type="supplementary-material">Supplement 3</xref>.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2025-09-26T10:00"><day>26</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>8</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">497707</issue-id><elocation-id>e2534275</elocation-id><history><date date-type="received"><day>5</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 00:25:15.170"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright 2025 Stamm B et al. <italic toggle="yes">JAMA Network Open</italic>.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jamanetwopen-e2534275.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jamanetwopen-e2534275.pdf">jamanetwopen-e2534275.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.34275"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" xml:lang="en" journal-id="JAMA Netw Open" journal-id-type="nlm-ta" ext-link-type="pubmed" xlink:href="41004152"><article-title>Next Steps in Improving Telestroke Systems of Care-From Reach to Efficiency.</article-title><volume>8</volume><issue>9</issue><date><day>2</day><month>9</month><year>2025</year></date><fpage>e2534282</fpage><lpage>e2534282</lpage><source>JAMA Netw Open</source><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2025.34282</pub-id><pub-id pub-id-type="pmid">41004152</pub-id></related-article><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-zoi250960-1"><title>Question</title><p>How do treatment times and stroke outcomes in patients with acute ischemic stroke evaluated by telestroke compare with those not evaluated by telestroke?</p></sec><sec id="ab-zoi250960-2"><title>Findings</title><p>In this cohort study of 3036 patients with acute ischemic stroke potentially eligible for thrombolysis, telestroke was associated with a higher odds of receiving thrombolysis, but significantly prolonged door-to-needle and door-in-door-out times and a lower odds of meeting guideline-concordant door-to-needle times within 60 minutes, compared with nontelestroke.</p></sec><sec id="ab-zoi250960-3"><title>Meaning</title><p>These findings suggest that there is room to improve timely stroke treatment for patients evaluated by telestroke to ensure that all patients with ischemic stroke receive guideline-concordant, time-sensitive care.</p></sec></abstract><abstract abstract-type="teaser" specific-use="electronic"><p>This cohort study evaluates the association of telestroke use with time to treatment and outcomes among patients with acute ischemic stroke in Michigan.</p></abstract><abstract><sec id="ab-zoi250960-4"><title>Importance</title><p>Telestroke has the potential to revolutionize acute stroke treatment by improving access to optimal stroke care, including time-sensitive care such as thrombolysis. However, it is unclear how treatment times and stroke outcomes compare between patients evaluated and not evaluated by telestroke.</p></sec><sec id="ab-zoi250960-5"><title>Objective</title><p>To evaluate the association between telestroke use and acute stroke treatment times and outcomes.</p></sec><sec id="ab-zoi250960-6"><title>Design, Setting, and Participants</title><p>This retrospective cohort study included patients with acute ischemic stroke aged 18 years or older presenting to 42 Paul Coverdell Michigan Stroke Registry hospitals from January 1, 2022, to December 31, 2023. All patients were potentially eligible for thrombolysis (ie, presented &#8804;4 hours of last known well, no contraindications to thrombolysis documented).</p></sec><sec id="ab-zoi250960-7"><title>Exposure</title><p>Telestroke (vs nontelestroke) encounter.</p></sec><sec id="ab-zoi250960-8"><title>Main Outcomes and Measures</title><p>The primary outcomes were receipt of thrombolysis and door-to-needle (DTN) time as a continuous variable and a categorical variable (&#8804;60 vs &gt;60 minutes). Secondary outcomes included discharge ambulatory status, discharge destination, and door-in-door-out (DIDO) time in transferred patients. Multivariable hierarchical models evaluated associations between telestroke (vs nontelestroke) activation and outcomes, sequentially adjusting for demographics, medical history, presentation or arrival, and hospital characteristics.</p></sec><sec id="ab-zoi250960-9"><title>Results</title><p>Among the 3036 patients with acute ischemic stroke potentially eligible for thrombolysis (mean [SD] age, 69.7 [14.5] years; 1563 male [51.5%]), 785 (25.9%) were evaluated using telestroke and 2251 (74.1%) without telestroke. A total of 1673 patients (55.1%) were treated with thrombolysis. In the fully adjusted models, patients evaluated by telestroke had a significantly higher odds of receiving thrombolysis (adjusted odds ratio, 1.61; 95% CI, 1.17-2.23) but longer DTN times (6.55 minutes longer; 95% CI, 2.12-10.97 minutes longer) and lower odds of meeting a guideline-concordant DTN time within 60 minutes (adjusted odds ratio, 0.56; 95% CI, 0.39-0.81) compared with those not evaluated by telestroke. Among 255 patients who underwent interhospital transfer, 207 (81.2%) received thrombolysis, and patients with telestroke had significantly longer DIDO times (46.90 minutes longer, 95% CI, 1.08-92.72 minutes longer).</p></sec><sec id="ab-zoi250960-10"><title>Conclusions and Relevance</title><p>In this cohort study of patients with acute ischemic stroke potentially eligible for thrombolysis, those evaluated by telestroke had a 61% higher odds of receiving thrombolysis but a 44% lower odds of meeting guideline-concordant DTN times within 60 minutes and prolonged DIDO times compared with those not evaluated by telestroke. Future research should investigate modifiable factors that contribute to treatment delays in patients with ischemic stroke evaluated via telestroke.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="H1-1-ZOI250960"><title>Introduction</title><p>Acute ischemic stroke (AIS) treatment is not only highly efficacious but also highly time-sensitive.<sup><xref rid="zoi250960r1" ref-type="bibr">1</xref>,<xref rid="zoi250960r2" ref-type="bibr">2</xref></sup> Faster time to treatment with intravenous thrombolysis (door to needle [DTN]) is associated with improved outcomes in AIS.<sup><xref rid="zoi250960r1" ref-type="bibr">1</xref></sup> For patients with a large vessel occlusion, approximately 1.9 million neurons die during each minute without treatment.<sup><xref rid="zoi250960r3" ref-type="bibr">3</xref></sup> Target: Stroke is a national quality improvement campaign by the American Heart Association (AHA) that achieved significant overall reductions in DTN times.<sup><xref rid="zoi250960r4" ref-type="bibr">4</xref>,<xref rid="zoi250960r5" ref-type="bibr">5</xref>,<xref rid="zoi250960r6" ref-type="bibr">6</xref></sup> Since its inception in 2010, Target: Stroke has set increasingly bold benchmarks for DTN times, with the most recent goal of achieving a DTN within 60 minutes in 85% of patients treated with intravenous thrombolysis.<sup><xref rid="zoi250960r7" ref-type="bibr">7</xref></sup></p><p>While thrombolysis is highly efficacious for acute stroke, not all hospitals have stroke specialists. Telestroke has revolutionized the treatment of acute stroke by improving access to expert stroke care.<sup><xref rid="zoi250960r8" ref-type="bibr">8</xref></sup> Telestroke connects stroke specialists (typically from a comprehensive stroke center or hub site) to spoke sites (typically primary stroke centers) to aid in acute stroke decision-making and treatment.<sup><xref rid="zoi250960r9" ref-type="bibr">9</xref></sup> Telestroke has led to an increased uptake of acute stroke therapies, including thrombolysis,<sup><xref rid="zoi250960r8" ref-type="bibr">8</xref></sup> and has grown across the nation, becoming a vital component of stroke systems of care.<sup><xref rid="zoi250960r8" ref-type="bibr">8</xref>,<xref rid="zoi250960r10" ref-type="bibr">10</xref></sup> However, several studies from single systems found that telestroke treatment times at spoke hospitals, including DTN times, were significantly prolonged,<sup><xref rid="zoi250960r11" ref-type="bibr">11</xref>,<xref rid="zoi250960r12" ref-type="bibr">12</xref>,<xref rid="zoi250960r13" ref-type="bibr">13</xref>,<xref rid="zoi250960r14" ref-type="bibr">14</xref>,<xref rid="zoi250960r15" ref-type="bibr">15</xref></sup> with worse inpatient and discharge stroke outcomes<sup><xref rid="zoi250960r12" ref-type="bibr">12</xref></sup> compared with standard, in-person stroke care.</p><p>A larger-scale comparison of telestroke vs standard stroke care has been difficult to perform given challenges with identifying patient-level telestroke encounters in standard administrative data. The Paul Coverdell Michigan Stroke Registry started routinely tracking telestroke encounters in 2022. This study used this state-level stroke registry to compare thrombolysis treatment rates, DTN times, and other evidence-based stroke hospitalization and discharge outcomes in patients evaluated via telestroke vs not.</p></sec><sec id="H1-2-ZOI250960"><title>Methods</title><p>In this cohort study, data were obtained from the Paul Coverdell Michigan Stroke Registry, a Centers for Disease Control and Prevention&#8211;funded, state-level program that collects stroke care data from the AHA&#8217;s Get With The Guidelines&#8211;Stroke registry to measure, track, and improve the quality of care for patients with stroke. Michigan has participated in the Coverdell program since its inception in 2003.<sup><xref rid="zoi250960r16" ref-type="bibr">16</xref></sup> The institutional review boards at both the Michigan Department of Health and Human Services and the University of Michigan approved this study. As the study was a secondary analysis of deidentified data, the institutional review boards exempted the study from informed consent. This study follows the Strengthening the Reporting of Observational Studies in Epidemiology (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.equator-network.org/reporting-guidelines/strobe/" ext-link-type="uri">STROBE</ext-link>) reporting guideline.<sup><xref rid="zoi250960r17" ref-type="bibr">17</xref></sup></p><sec id="H2-1-ZOI250960"><title>Study Population</title><p>All patients aged 18 years or older presenting to Paul Coverdell Michigan hospitals between January 1, 2022 (when the telestroke variable was first routinely used), and December 31, 2023, with a diagnosis of AIS and a nonmissing response to the Get With The Guidelines&#8211;Stroke question, &#8220;Was telestroke consultation performed,&#8221; were included. Patients with any of the following criteria were excluded: (1) diagnosis of intracerebral hemorrhage, subarachnoid hemorrhage, or transient ischemic attack; (2) inpatient stroke; (3) transported by mobile stroke unit; (4) ineligible for thrombolysis (last known well&#8211;to&#8211;emergency department arrival time &gt;4 hours or met other standard exclusion criteria)<sup><xref rid="zoi250960r18" ref-type="bibr">18</xref></sup>; and (5) missing data on hospital arrival method, receipt of thrombolysis, National Institutes of Health Stroke Scale (NIHSS) score at admission, or other key covariates as detailed herein the Methods. For patients who underwent an interhospital transfer, data were obtained from the sending facility. eFigure 1 in <xref rid="note-ZOI250960-1-s" ref-type="supplementary-material">Supplement 2</xref> depicts the study derivation.</p></sec><sec id="H2-2-ZOI250960"><title>Primary Exposure</title><p>The primary independent variable was telestroke activation (vs no telestroke activation). Telestroke activation was defined by a response of, &#8220;Yes, the patient received telestroke consultation from a remotely located expert when the patient was located at my hospital,&#8221; to the to the Get With The Guidelines&#8211;Stroke question, &#8220;Was telestroke consultation performed?&#8221;</p></sec><sec id="H2-3-ZOI250960"><title>Outcomes</title><p>The primary outcomes were receipt of thrombolysis and DTN time as continuous and categorical variables (&#8804;60 vs &gt;60 minutes) per current AIS guidelines.<sup><xref rid="zoi250960r19" ref-type="bibr">19</xref></sup> Secondary outcomes included postthrombolytic symptomatic intracerebral hemorrhage, in-hospital mortality, ordinal discharge modified Rankin Scale (mRS) score, discharge ambulatory status (ambulatory vs nonambulatory), discharge destination (home vs other [acute care facility, other health care facility, left against medical advice, hospice, or death]), and DTN time (&#8804;45 vs &gt;45 minutes), per Target: Stroke recommendations,<sup><xref rid="zoi250960r7" ref-type="bibr">7</xref></sup> and among those transferred to another hospital, door-in-door-out (DIDO) time (minutes).</p></sec><sec id="H2-4-ZOI250960"><title>Prespecified Covariates</title><p>Patient-level demographics included age (years), sex (male vs female), race and ethnicity (Hispanic, non-Hispanic Black [hereafter, Black], non-Hispanic White [hereafter, White], non-Hispanic other [Asian, American Indian or Alaska Native, Native Hawaiian or Pacific Islander, and unable to determine; hereafter, other] as abstracted from the medical record). Medical history variables included atrial fibrillation, stroke, heart failure, diabetes, hypertension, and cigarette smoking. Race and ethnicity were included as covariates given known racial and ethnic disparities in various acute stroke processes.</p><p>Presenting and arrival covariates included last known well&#8211;to&#8211;arrival time (per minute increase), large vessel occlusion, NIHSS score categories (0-4 [no or minor stroke], 5-15 [moderate stroke], 16-20 [moderate to severe stroke], 21-42 [severe stroke]),<sup><xref rid="zoi250960r20" ref-type="bibr">20</xref></sup> arrival method (eg, use of emergency medical services [EMS] vs private transportation), EMS prenotification (advanced emergency department notification by EMS of suspected stroke),<sup><xref rid="zoi250960r21" ref-type="bibr">21</xref></sup> off-hours arrival time (regular [nonholiday] hours 7:00 <sc>am</sc> to 6:00 <sc>pm</sc>, Monday through Friday),<sup><xref rid="zoi250960r22" ref-type="bibr">22</xref></sup> door&#8211;to&#8211;computed tomography imaging time (&#8804;20 minutes),<sup><xref rid="zoi250960r19" ref-type="bibr">19</xref></sup> and transfer to another hospital. Hospital characteristics included geographic location (metropolitan hospital, yes or no), teaching hospital (yes or no), presence of a neurology residency program (yes or no), Joint Commission stroke center status (primary stroke center, thrombectomy-capable stroke center, comprehensive stroke center, noncertified hospital),<sup><xref rid="zoi250960r23" ref-type="bibr">23</xref></sup> and annual number of ischemic stroke discharges (&lt;200, 200-600, &gt;600).</p></sec><sec id="H2-5-ZOI250960"><title>Statistical Analysis</title><p>Descriptive statistics, including proportions, means and SDs, and medians and IQRs, were performed as appropriate. The differences in covariates, primary and secondary outcomes between the groups (telestroke vs nontelestroke) were tested using &#967;<sup>2</sup> tests (or Fisher exact tests) and Wilcoxon rank sum tests, as appropriate. Hospital characteristics were also compared between telestroke hospitals (defined as hospitals that had at least 1 telestroke encounter during the study period) vs nontelestroke hospitals.</p><sec id="H3-1-ZOI250960"><title>Primary Analysis</title><p>Sequential multilevel modeling was used to estimate the variation and factors associated with outcomes at the patient and hospital level. Model 1 contained the hospital-specific random intercepts to account for patient clustering within each hospital. This model was used to estimate the intraclass correlation coefficient to calculate hospital-level variation in outcomes. Model 2 added patient-level factors (including demographics, medical history, and presenting or arrival factors) to model 1. Model 3 added hospital-level covariates to model 2. These sequential models were performed for each primary outcome and for secondary outcomes with statistically significant (<italic toggle="yes">P</italic> &lt; .05) bivariate comparisons. An exploratory model 4 tested for effect modification by adding telestroke&#8211;by&#8211;off-hours arrival time and telestroke&#8211;by&#8211;stroke center status interaction terms, respectively, into the fully adjusted DTN outcome models to examine whether delays were concentrated in specific settings.</p><p>Secondary outcome multivariable regression models were performed among patients who received thrombolysis, given the association between thrombolysis and hospital discharge outcomes.<sup><xref rid="zoi250960r1" ref-type="bibr">1</xref></sup> Given the relatively low sample size of patients transferred to another hospital who had received thrombolysis, the multivariable model for the secondary outcome of DIDO time only adjusted for patient-level factors, but patient clustering within hospitals was accounted for by the multilevel model.</p></sec><sec id="H3-2-ZOI250960"><title>Sensitivity Analysis</title><p>Given prior literature showing differential characteristics and outcomes of patients with AIS by transfer status,<sup><xref rid="zoi250960r24" ref-type="bibr">24</xref></sup> a sensitivity analysis was performed that removed transferred patients. An additional sensitivity analysis was performed in which missing responses to the telestroke activation variable were imputed to no.</p><p>All statistical analyses were performed using StataSE, version 19 (StataCorp LLC). Statistical significance was set at a 2-sided <italic toggle="yes">P</italic> &lt; .05.</p></sec></sec></sec><sec id="H1-3-ZOI250960"><title>Results</title><p>Among the 3036 patients with confirmed AIS who were potentially eligible for thrombolysis (mean [SD] age, 69.7 [14.5] years; 1473 female [48.5%] and 1563 male [51.5%]; 490 of Black [16.1%], 63 of Hispanic [2.1%], 2354 of White [77.5%], and 129 of other [4.2%] race and ethnicity), 785 (25.9%) were evaluated using telestroke and 2251 (74.1%) without telestroke (<xref rid="zoi250960t1" ref-type="table">Table 1</xref>). Patients evaluated by telestroke had significantly shorter last known well&#8211;to&#8211;arrival times (median [IQR], 65.0 [38.0-120.0] vs 75.0 [47.0-128.0] minutes; <italic toggle="yes">P</italic> &lt; .001), a greater proportion of large vessel occlusion (26.5% vs 21.4%; <italic toggle="yes">P</italic> = .003), higher NIHSS scores (8.5% vs 5.6% for severe stroke; <italic toggle="yes">P</italic> = .001), and a greater proportion with door&#8211;to&#8211;computed tomography time within 20 minutes (71.3% vs 65.9%; <italic toggle="yes">P</italic> = .005) (<xref rid="zoi250960t1" ref-type="table">Table 1</xref>). The proportion of patients evaluated by telestroke was significantly lower at metropolitan facilities (79.4% vs 90.1%), teaching hospitals (65.9% vs 87.3%), hospitals with a neurology residency program (10.6% vs 41.2%), and comprehensive stroke centers (18.1% vs 54.2%) (all <italic toggle="yes">P</italic> &lt; .001) (<xref rid="zoi250960t1" ref-type="table">Table 1</xref>).</p><table-wrap position="float" id="zoi250960t1" orientation="portrait"><label>Table 1. </label><caption><title>Baseline Patient (N = 3036) and Hospital Characteristics Stratified by Telestroke Activation</title></caption><table frame="hsides" rules="groups"><col width="47.56%" span="1"/><col width="22.59%" span="1"/><col width="22.61%" span="1"/><col width="7.24%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="rowgroup" colspan="1">Characteristic</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Telestroke activation, No. (%)</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><italic toggle="yes">P</italic> value<xref rid="zoi250960t1n1" ref-type="table-fn"><sup>a</sup></xref></th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Yes (n&#8201;=&#8201;785)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">No (n&#8201;=&#8201;2251)</th></tr></thead><tbody><tr><td colspan="4" valign="top" align="left" scope="col" rowspan="1">
<bold>Patient demographics</bold>
</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age at time of stroke, median (IQR) [range], y</td><td valign="top" align="left" rowspan="1" colspan="1">72.0 (62.0-81.0) [18.0-101.0]</td><td valign="top" align="left" rowspan="1" colspan="1">70.0 (60.0-80.0) [18.0-102.0]</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Female</td><td valign="top" align="left" rowspan="1" colspan="1">403 (51.3)</td><td valign="top" align="left" rowspan="1" colspan="1">1070 (47.5)</td><td rowspan="2" valign="middle" align="left" colspan="1">.07</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Male</td><td valign="top" align="left" rowspan="1" colspan="1">382 (48.7)</td><td valign="top" align="left" rowspan="1" colspan="1">1181 (52.5)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Race and ethnicity, No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Black</td><td valign="top" align="left" rowspan="1" colspan="1">95 (12.1)</td><td valign="top" align="left" rowspan="1" colspan="1">395 (17.5)</td><td rowspan="4" valign="middle" align="left" colspan="1">.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hispanic</td><td valign="top" align="left" rowspan="1" colspan="1">11 (1.4)</td><td valign="top" align="left" rowspan="1" colspan="1">52 (2.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> White</td><td valign="top" align="left" rowspan="1" colspan="1">646 (82.3)</td><td valign="top" align="left" rowspan="1" colspan="1">1708 (75.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other<xref rid="zoi250960t1n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">33 (4.2)</td><td valign="top" align="left" rowspan="1" colspan="1">96 (4.3)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Medical history</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Atrial fibrillation or flutter</td><td valign="top" align="left" rowspan="1" colspan="1">124 (15.8)</td><td valign="top" align="left" rowspan="1" colspan="1">295 (13.1)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Prior stroke or transient ischemic attack</td><td valign="top" align="left" rowspan="1" colspan="1">246 (31.3)</td><td valign="top" align="left" rowspan="1" colspan="1">669 (29.7)</td><td valign="top" align="left" rowspan="1" colspan="1">.40</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Prior heart failure</td><td valign="top" align="left" rowspan="1" colspan="1">84 (10.7)</td><td valign="top" align="left" rowspan="1" colspan="1">226 (10.0)</td><td valign="top" align="left" rowspan="1" colspan="1">.60</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Diabetes</td><td valign="top" align="left" rowspan="1" colspan="1">220 (28.0)</td><td valign="top" align="left" rowspan="1" colspan="1">689 (30.6)</td><td valign="top" align="left" rowspan="1" colspan="1">.17</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hypertension</td><td valign="top" align="left" rowspan="1" colspan="1">613 (78.1)</td><td valign="top" align="left" rowspan="1" colspan="1">1669 (74.1)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Cigarette smoking</td><td valign="top" align="left" rowspan="1" colspan="1">149 (19.0)</td><td valign="top" align="left" rowspan="1" colspan="1">435 (19.3)</td><td valign="top" align="left" rowspan="1" colspan="1">.83</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Stroke presentation</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Last known well to arrival time, median (IQR), min</td><td valign="top" align="left" rowspan="1" colspan="1">65.0 (38.0-120.0)</td><td valign="top" align="left" rowspan="1" colspan="1">75.0 (47.0-128.0)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Large vessel occlusion</td><td valign="top" align="left" rowspan="1" colspan="1">208 (26.5)</td><td valign="top" align="left" rowspan="1" colspan="1">482 (21.4)</td><td valign="top" align="left" rowspan="1" colspan="1">.003</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> NIHSS score</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 0-4 (No or mild stroke)</td><td valign="top" align="left" rowspan="1" colspan="1">394 (50.2)</td><td valign="top" align="left" rowspan="1" colspan="1">1291 (57.4)</td><td rowspan="4" valign="middle" align="left" colspan="1">.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 5-15</td><td valign="top" align="left" rowspan="1" colspan="1">276 (35.2)</td><td valign="top" align="left" rowspan="1" colspan="1">716 (31.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 16-20</td><td valign="top" align="left" rowspan="1" colspan="1">48 (6.1)</td><td valign="top" align="left" rowspan="1" colspan="1">117 (5.2)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 21-42 (Severe stroke)</td><td valign="top" align="left" rowspan="1" colspan="1">67 (8.5)</td><td valign="top" align="left" rowspan="1" colspan="1">127 (5.6)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Arrival and transfer characteristics</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Arrival mode</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Private transportation</td><td valign="top" align="left" rowspan="1" colspan="1">243 (31.0)</td><td valign="top" align="left" rowspan="1" colspan="1">697 (31.0)</td><td rowspan="3" valign="middle" align="left" colspan="1">.20</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> EMS no prenotification</td><td valign="top" align="left" rowspan="1" colspan="1">215 (27.4)</td><td valign="top" align="left" rowspan="1" colspan="1">549 (24.4)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> EMS prenotification</td><td valign="top" align="left" rowspan="1" colspan="1">327 (41.7)</td><td valign="top" align="left" rowspan="1" colspan="1">1005 (44.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Off-hours arrival time<xref rid="zoi250960t1n3" ref-type="table-fn"><sup>c</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">423 (53.9)</td><td valign="top" align="left" rowspan="1" colspan="1">1276 (56.7)</td><td valign="top" align="left" rowspan="1" colspan="1">.17</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Door-to-CT time &#8804;20 min</td><td valign="top" align="left" rowspan="1" colspan="1">560 (71.3)</td><td valign="top" align="left" rowspan="1" colspan="1">1484 (65.9)</td><td valign="top" align="left" rowspan="1" colspan="1">.005</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Transferred to another hospital</td><td valign="top" align="left" rowspan="1" colspan="1">71 (9.0)</td><td valign="top" align="left" rowspan="1" colspan="1">19 (0.8)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td colspan="4" valign="top" align="left" scope="col" rowspan="1">
<bold>Hospital characteristics</bold>
</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Metropolitan</td><td valign="top" align="left" rowspan="1" colspan="1">623 (79.4)</td><td valign="top" align="left" rowspan="1" colspan="1">2028 (90.1)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Teaching</td><td valign="top" align="left" rowspan="1" colspan="1">517 (65.9)</td><td valign="top" align="left" rowspan="1" colspan="1">1964 (87.3)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Presence of a neurology residency program</td><td valign="top" align="left" rowspan="1" colspan="1">83 (10.6)</td><td valign="top" align="left" rowspan="1" colspan="1">928 (41.2)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Stroke center status</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Comprehensive</td><td valign="top" align="left" rowspan="1" colspan="1">142 (18.1)</td><td valign="top" align="left" rowspan="1" colspan="1">1220 (54.2)</td><td rowspan="4" valign="middle" align="left" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Thrombectomy capable</td><td valign="top" align="left" rowspan="1" colspan="1">111 (14.1)</td><td valign="top" align="left" rowspan="1" colspan="1">156 (6.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Primary</td><td valign="top" align="left" rowspan="1" colspan="1">517 (65.9)</td><td valign="top" align="left" rowspan="1" colspan="1">875 (38.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Not certified</td><td valign="top" align="left" rowspan="1" colspan="1">15 (1.9)</td><td valign="top" align="left" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Annual No. of acute stroke discharges</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &lt;200</td><td valign="top" align="left" rowspan="1" colspan="1">115 (14.6)</td><td valign="top" align="left" rowspan="1" colspan="1">11 (0.5)</td><td rowspan="3" valign="middle" align="left" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 200-600</td><td valign="top" align="left" rowspan="1" colspan="1">546 (69.6)</td><td valign="top" align="left" rowspan="1" colspan="1">1170 (52.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &gt;600</td><td valign="top" align="left" rowspan="1" colspan="1">124 (15.8)</td><td valign="top" align="left" rowspan="1" colspan="1">1070 (47.5)</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: CT, computed tomography; EMS, emergency medical services; NIHSS, National Institutes of Health Stroke Scale.</p><fn id="zoi250960t1n1"><label>
<sup>a</sup>
</label><p>Differences between continuous variables were assessed using Mann-Whitney <italic toggle="yes">U </italic>tests, and differences between categorical variables were assessed using &#967;<sup>2</sup> tests.</p></fn><fn id="zoi250960t1n2"><label>
<sup>b</sup>
</label><p>Other included Asian, American Indian or Alaska Native, Native Hawaiian or Pacific Islander, and unable to determine.</p></fn><fn id="zoi250960t1n3"><label>
<sup>c</sup>
</label><p>Regular (nonholiday) hours are 7:00 <sc>am</sc> to 6:00 <sc>pm</sc>, Monday through Friday.</p></fn></table-wrap-foot></table-wrap><p>Thrombolysis was administered to 1673 patients, including 436 of 785 potentially eligible patients (55.5%) evaluated by telestroke vs 1237 of 2251 (55.0%) not evaluated by telestroke (<italic toggle="yes">P</italic>&#8201;=&#8201;.78) (<xref rid="zoi250960t2" ref-type="table">Table 2</xref>). Patients evaluated by telestroke had longer median DTN times (53.0 [IQR, 40.0-74.0] vs 46.0 [IQR, 33.0-64.0] minutes; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). Among transferred patients, those evaluated by telestroke had longer median DIDO times (166.0 [IQR, 92.0-252.0] vs 150.0 [IQR, 103.0-235.5] minutes; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). Fewer patients evaluated by telestroke met guideline-concordant DTN times within 60 minutes compared with those not treated by telestroke (263 of 436 [60.3%] vs 894 of 1237 [72.3%]; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001).</p><table-wrap position="float" id="zoi250960t2" orientation="portrait"><label>Table 2. </label><caption><title>Primary and Secondary Outcomes Stratified by Telestroke Activation, Unadjusted</title></caption><table frame="hsides" rules="groups"><col width="21.84%" span="1"/><col width="15.55%" span="1"/><col width="14.24%" span="1"/><col width="9.29%" span="1"/><col width="15.55%" span="1"/><col width="14.24%" span="1"/><col width="9.29%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="rowgroup" colspan="1">Outcome</th><th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">Patients eligible for thrombolysis (N&#8201;=&#8201;3036)</th><th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">Patients who received thrombolysis (n&#8201;=&#8201;1673)</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Telestroke activation (n&#8201;=&#8201;785)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">No telestroke (n&#8201;=&#8201;2251)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value<xref rid="zoi250960t2n1" ref-type="table-fn"><sup>a</sup></xref></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Telestroke activation (n&#8201;=&#8201;436)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">No telestroke (n&#8201;=&#8201;1237)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value<xref rid="zoi250960t2n1" ref-type="table-fn"><sup>a</sup></xref></th></tr></thead><tbody><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1">
<bold>Primary</bold>
</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Thrombolysis administered, No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1">436 (55.5)</td><td valign="top" align="left" rowspan="1" colspan="1">1237 (55.0)</td><td valign="top" align="left" rowspan="1" colspan="1">.78</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">DTN time, median (IQR), min</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">53.0 (40.0-74.0)</td><td valign="top" align="left" rowspan="1" colspan="1">46.0 (33.0-64.0)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1">
<bold>Secondary outcomes</bold>
</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Postthrombolytic ICH, No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">11 (2.5)</td><td valign="top" align="left" rowspan="1" colspan="1">33 (2.7)</td><td valign="top" align="left" rowspan="1" colspan="1">.87</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">In-hospital mortality, No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1">23 (2.9)</td><td valign="top" align="left" rowspan="1" colspan="1">67 (3.0)</td><td valign="top" align="left" rowspan="1" colspan="1">.95</td><td valign="top" align="left" rowspan="1" colspan="1">15 (3.4)</td><td valign="top" align="left" rowspan="1" colspan="1">52 (4.2)</td><td valign="top" align="left" rowspan="1" colspan="1">.48</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Discharge mRS, median (IQR), points<xref rid="zoi250960t2n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">2.0 (0.0-4.0)</td><td valign="top" align="left" rowspan="1" colspan="1">1.0 (0.0-4.0)</td><td valign="top" align="left" rowspan="1" colspan="1">.008</td><td valign="top" align="left" rowspan="1" colspan="1">2.0 (1.0-4.0)</td><td valign="top" align="left" rowspan="1" colspan="1">2.0 (1.0-4.0)</td><td valign="top" align="left" rowspan="1" colspan="1">.008</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Discharge mRS, No. (%), points<xref rid="zoi250960t2n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 0 (No symptoms)</td><td valign="top" align="left" rowspan="1" colspan="1">88 (25.4)</td><td valign="top" align="left" rowspan="1" colspan="1">372 (28.2)</td><td rowspan="7" valign="middle" align="left" colspan="1">.008</td><td valign="top" align="left" rowspan="1" colspan="1">39 (20.2)</td><td valign="top" align="left" rowspan="1" colspan="1">175 (22.9)</td><td rowspan="7" valign="middle" align="left" colspan="1">.10</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 1</td><td valign="top" align="left" rowspan="1" colspan="1">75 (21.6)</td><td valign="top" align="left" rowspan="1" colspan="1">334 (25.3)</td><td valign="top" colspan="1" align="left" rowspan="1">48 (24.9)</td><td valign="top" align="left" rowspan="1" colspan="1">184 (24.1)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 2</td><td valign="top" align="left" rowspan="1" colspan="1">39 (11.2)</td><td valign="top" align="left" rowspan="1" colspan="1">136 (10.3)</td><td valign="top" colspan="1" align="left" rowspan="1">24 (12.4)</td><td valign="top" align="left" rowspan="1" colspan="1">89 (11.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 3</td><td valign="top" align="left" rowspan="1" colspan="1">27 (7.8)</td><td valign="top" align="left" rowspan="1" colspan="1">137 (10.4)</td><td valign="top" colspan="1" align="left" rowspan="1">11 (5.7)</td><td valign="top" align="left" rowspan="1" colspan="1">80 (10.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 4</td><td valign="top" align="left" rowspan="1" colspan="1">68 (19.6)</td><td valign="top" align="left" rowspan="1" colspan="1">235 (17.8)</td><td valign="top" colspan="1" align="left" rowspan="1">37 (19.2)</td><td valign="top" align="left" rowspan="1" colspan="1">155 (20.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 5</td><td valign="top" align="left" rowspan="1" colspan="1">27 (7.8)</td><td valign="top" align="left" rowspan="1" colspan="1">56 (4.2)</td><td valign="top" colspan="1" align="left" rowspan="1">19 (9.8)</td><td valign="top" align="left" rowspan="1" colspan="1">42 (5.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 6 (Death)</td><td valign="top" align="left" rowspan="1" colspan="1">23 (6.6)</td><td valign="top" align="left" rowspan="1" colspan="1">49 (3.7)</td><td valign="top" colspan="1" align="left" rowspan="1">15 (7.8)</td><td valign="top" align="left" rowspan="1" colspan="1">40 (5.2)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Ambulatory status at discharge, No. (%)<xref rid="zoi250960t2n3" ref-type="table-fn"><sup>c</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Independent</td><td valign="top" align="left" rowspan="1" colspan="1">420 (62.7)</td><td valign="top" align="left" rowspan="1" colspan="1">1225 (70.1)</td><td rowspan="3" valign="middle" align="left" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">208 (60.1)</td><td valign="top" align="left" rowspan="1" colspan="1">614 (65.8)</td><td rowspan="3" valign="middle" align="left" colspan="1">.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> With assistance from another person</td><td valign="top" align="left" rowspan="1" colspan="1">166 (24.8)</td><td valign="top" align="left" rowspan="1" colspan="1">386 (22.1)</td><td valign="top" colspan="1" align="left" rowspan="1">84 (24.3)</td><td valign="top" align="left" rowspan="1" colspan="1">226 (24.2)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Unable</td><td valign="top" align="left" rowspan="1" colspan="1">84 (12.5)</td><td valign="top" align="left" rowspan="1" colspan="1">136 (7.8)</td><td valign="top" colspan="1" align="left" rowspan="1">54 (15.6)</td><td valign="top" align="left" rowspan="1" colspan="1">93 (10.0)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Discharge destination, No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Home</td><td valign="top" align="left" rowspan="1" colspan="1">441 (56.2)</td><td valign="top" align="left" rowspan="1" colspan="1">1409 (62.6)</td><td rowspan="5" valign="middle" align="left" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">441 (56.2)</td><td valign="top" align="left" rowspan="1" colspan="1">1409 (62.6)</td><td rowspan="5" valign="middle" align="left" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Acute care facility</td><td valign="top" align="left" rowspan="1" colspan="1">90 (11.5)</td><td valign="top" align="left" rowspan="1" colspan="1">25 (1.1)</td><td valign="top" colspan="1" align="left" rowspan="1">90 (11.5)</td><td valign="top" align="left" rowspan="1" colspan="1">25 (1.1)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other health care facility</td><td valign="top" align="left" rowspan="1" colspan="1">179 (22.8)</td><td valign="top" align="left" rowspan="1" colspan="1">616 (27.4)</td><td valign="top" colspan="1" align="left" rowspan="1">179 (22.8)</td><td valign="top" align="left" rowspan="1" colspan="1">616 (27.4)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Left against medical advice</td><td valign="top" align="left" rowspan="1" colspan="1">13 (1.7)</td><td valign="top" align="left" rowspan="1" colspan="1">46 (2.0)</td><td valign="top" colspan="1" align="left" rowspan="1">13 (1.7)</td><td valign="top" align="left" rowspan="1" colspan="1">46 (2.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hospice or died</td><td valign="top" align="left" rowspan="1" colspan="1">62 (7.9)</td><td valign="top" align="left" rowspan="1" colspan="1">155 (6.9)</td><td valign="top" colspan="1" align="left" rowspan="1">62 (7.9)</td><td valign="top" align="left" rowspan="1" colspan="1">155 (6.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">DIDO time, median (IQR), min<xref rid="zoi250960t2n4" ref-type="table-fn"><sup>d</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">166.0 (92.0-252.0)</td><td valign="top" align="left" rowspan="1" colspan="1">150.0 (103.0-235.5)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">142.0 (88.0-230.0)</td><td valign="top" align="left" rowspan="1" colspan="1">123.0 (96.0-192.0)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: DIDO, door-in-door-out; DTN, door-to-needle; ICH, intracerebral hemorrhage; mRS, modified Rankin Scale; NA, not applicable.</p><fn id="zoi250960t2n1"><label>
<sup>a</sup>
</label><p>Differences between continuous variables were assessed using Mann-Whitney <italic toggle="yes">U</italic> test, and differences between categorical variables were assessed using &#967;<sup>2</sup> test.</p></fn><fn id="zoi250960t2n2"><label>
<sup>b</sup>
</label><p>Assessed in a subset of patients with documented mRS score at discharge (n&#8201;=&#8201;1666).</p></fn><fn id="zoi250960t2n3"><label>
<sup>c</sup>
</label><p>Assessed in a subset of patients who were able to ambulate independently prior to admission (n&#8201;=&#8201;2653).</p></fn><fn id="zoi250960t2n4"><label>
<sup>d</sup>
</label><p>Assessed in a subset of patients who were transferred to another hospital (n&#8201;=&#8201;255).</p></fn></table-wrap-foot></table-wrap><p>Nontelestroke hospitals (n&#8201;=&#8201;20) compared with telestroke hospitals (n&#8201;=&#8201;22) were more often teaching hospitals (20 [100%] vs 13 [59.1%]; <italic toggle="yes">P</italic> = .001), in a metropolitan location (20 [100%] vs 15 [68.2%]; <italic toggle="yes">P</italic> = .006), and with a higher annual number of acute stroke discharges (&#8805;200 discharges: 20 [100%] vs 15 [68.2%]; <italic toggle="yes">P</italic> = .01) (eTable 1 in <xref rid="note-ZOI250960-1-s" ref-type="supplementary-material">Supplement 1</xref>). There was variation in telestroke use at the hospital level (eFigure 2 in <xref rid="note-ZOI250960-1-s" ref-type="supplementary-material">Supplement 2</xref>).</p><p>Calculated intraclass correlation coefficients for the empty models with only hospital random intercepts included were 0.12 for the outcome of receipt of thrombolysis and 0.10 for both continuous and dichotomous DTN time outcomes. In the fully adjusted model 3, patients evaluated by telestroke had a higher odds of receiving thrombolysis compared with those who were not (adjusted odds ratio, 1.61; 95% CI, 1.17-2.23; <italic toggle="yes">P</italic>&#8201;=&#8201;.003). Other factors associated with receipt of thrombolysis are listed in <xref rid="zoi250960t3" ref-type="table">Table 3</xref>. After adjusting for patient-level factors, patients evaluated by telestroke had significantly longer DTN times (7.44 minutes longer; 95% CI, 2.97-11.90 minutes longer; <italic toggle="yes">P</italic>&#8201;=&#8201;.001). This difference was slightly attenuated after adjustment for hospital characteristics (6.55 minutes longer; 95% CI, 2.12-10.97 minutes longer; <italic toggle="yes">P</italic>&#8201;=&#8201;.003) (<xref rid="zoi250960t4" ref-type="table">Table 4</xref>). There was no evidence of significant telestroke&#8211;by&#8211;off-hours arrival time or telestroke&#8211;by&#8211;stroke center status interactions for DTN time. In the fully adjusted multilevel model of guideline-concordant DTN time within 60 minutes, patients evaluated by telestroke had a lower odds of receiving thrombolysis within 60 minutes compared with those who were not (adjusted odds ratio, 0.56; 95% CI, 0.39-0.81; <italic toggle="yes">P</italic>&#8201;=&#8201;.002) (<xref rid="zoi250960t5" ref-type="table">Table 5</xref>).</p><table-wrap position="float" id="zoi250960t3" orientation="portrait"><label>Table 3. </label><caption><title>Multilevel Model of Receipt of Thrombolysis by Telestroke Activation, With and Without Adjustment for Patient and Hospital Characteristics (N&#8201;=&#8201;3036)</title></caption><table frame="hsides" rules="groups"><col width="25.01%" span="1"/><col width="15.64%" span="1"/><col width="8.45%" span="1"/><col width="15.34%" span="1"/><col width="9.04%" span="1"/><col width="16.91%" span="1"/><col width="9.61%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="rowgroup" colspan="1">Coefficient</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Model 1: unadjusted</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Model 2: adjusted for patient characteristics<xref rid="zoi250960t3n1" ref-type="table-fn"><sup>a</sup></xref></th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Model 3: further adjusted for patient and hospital characteristics<xref rid="zoi250960t3n2" ref-type="table-fn"><sup>b</sup></xref></th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">OR (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">AOR (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">AOR (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Telestroke activation, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">2.24 (1.70-2.94)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">1.48 (1.08-2.04)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td><td valign="top" align="left" rowspan="1" colspan="1">1.61 (1.17-2.23)</td><td valign="top" align="left" rowspan="1" colspan="1">.003</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, per 1-y increase</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.99 (0.98-0.99)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.99 (0.98-0.99)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sex, female vs male</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.84 (0.71-1.01)</td><td valign="top" align="left" rowspan="1" colspan="1">.059</td><td valign="top" align="left" rowspan="1" colspan="1">0.84 (0.71-1.01)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Race and ethnicity (reference group, White)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Black</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.86 (0.64-1.14)</td><td valign="top" align="left" rowspan="1" colspan="1">.29</td><td valign="top" align="left" rowspan="1" colspan="1">0.83 (0.63-1.11)</td><td valign="top" align="left" rowspan="1" colspan="1">.21</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hispanic</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.95 (0.52-1.72)</td><td valign="top" align="left" rowspan="1" colspan="1">.85</td><td valign="top" align="left" rowspan="1" colspan="1">0.92 (0.51-1.67)</td><td valign="top" align="left" rowspan="1" colspan="1">.78</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other<xref rid="zoi250960t3n3" ref-type="table-fn"><sup>c</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.27 (0.79-2.04)</td><td valign="top" align="left" rowspan="1" colspan="1">.31</td><td valign="top" align="left" rowspan="1" colspan="1">1.25 (0.78-2.01)</td><td valign="top" align="left" rowspan="1" colspan="1">.35</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of atrial fibrillation, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.77 (0.59-1.01)</td><td valign="top" align="left" rowspan="1" colspan="1">.056</td><td valign="top" align="left" rowspan="1" colspan="1">0.77 (0.59-1.01)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of stroke, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.72 (0.59-0.88)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.72 (0.59-0.87)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of heart failure, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.92 (0.68-1.24)</td><td valign="top" align="left" rowspan="1" colspan="1">.57</td><td valign="top" align="left" rowspan="1" colspan="1">0.92 (0.68-1.24)</td><td valign="top" align="left" rowspan="1" colspan="1">.59</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of diabetes, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.98 (0.80-1.19)</td><td valign="top" align="left" rowspan="1" colspan="1">.81</td><td valign="top" align="left" rowspan="1" colspan="1">0.98 (0.80-1.20)</td><td valign="top" align="left" rowspan="1" colspan="1">.85</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of hypertension, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.95 (0.76-1.18)</td><td valign="top" align="left" rowspan="1" colspan="1">.62</td><td valign="top" align="left" rowspan="1" colspan="1">0.95 (0.76-1.19)</td><td valign="top" align="left" rowspan="1" colspan="1">.65</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of cigarette smoking, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.00 (0.79-1.26)</td><td valign="top" align="left" rowspan="1" colspan="1">.99</td><td valign="top" align="left" rowspan="1" colspan="1">1.01 (0.80-1.27)</td><td valign="top" align="left" rowspan="1" colspan="1">.95</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Last known well to arrival time, per 1-min increase</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.99 (0.99-1.00)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.99 (0.99-1.00)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Large vessel occlusion, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.61 (1.25-2.06)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">1.57 (1.23-2.02)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">NIHSS category<xref rid="zoi250960t3n4" ref-type="table-fn"><sup>d</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 5-15 vs 0-4 points</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">6.51 (5.27-8.03)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">6.50 (5.26-8.02)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 16-20 vs 0-4 points</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">8.74 (5.39-14.15)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">8.79 (5.42-14.24)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 21-42 vs 0-4 points</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">6.73 (4.38-10.33)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">6.68 (4.34-10.26)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Arrival method</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> EMS no prenotification vs private transportation</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.85 (0.66-1.08)</td><td valign="top" align="left" rowspan="1" colspan="1">.18</td><td valign="top" align="left" rowspan="1" colspan="1">0.84 (0.65-1.07)</td><td valign="top" align="left" rowspan="1" colspan="1">.16</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> EMS prenotification vs private transportation</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.06 (0.85-1.34)</td><td valign="top" align="left" rowspan="1" colspan="1">.59</td><td valign="top" align="left" rowspan="1" colspan="1">1.05 (0.83-1.31)</td><td valign="top" align="left" rowspan="1" colspan="1">.70</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Off-hours arrival, yes vs no<xref rid="zoi250960t3n5" ref-type="table-fn"><sup>e</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.98 (0.82-1.16)</td><td valign="top" align="left" rowspan="1" colspan="1">.79</td><td valign="top" align="left" rowspan="1" colspan="1">0.98 (0.82-1.17)</td><td valign="top" align="left" rowspan="1" colspan="1">.82</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Door-to-CT time &#8804;20 min, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">2.79 (2.28-3.42)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">2.80 (2.28-3.43)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Transfer to another hospital, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">4.03 (1.85-8.76)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">5.59 (2.34-13.38)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Metropolitan hospital, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.03 (0.41-2.56)</td><td valign="top" align="left" rowspan="1" colspan="1">.94</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Teaching hospital, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.36 (0.63-2.94)</td><td valign="top" align="left" rowspan="1" colspan="1">.43</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Neurology residency program, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.16 (0.66-2.05)</td><td valign="top" align="left" rowspan="1" colspan="1">.61</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Stroke center status</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Thrombectomy-capable vs comprehensive</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.91 (0.74-4.92)</td><td valign="top" align="left" rowspan="1" colspan="1">.17</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Primary vs comprehensive</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.84 (0.46-1.54)</td><td valign="top" align="left" rowspan="1" colspan="1">.57</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Not certified vs comprehensive</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.58 (0.07-5.20)</td><td valign="top" align="left" rowspan="1" colspan="1">.62</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Annual No. of acute stroke discharges</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 200-600 vs &lt;200</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">2.26 (0.90-5.67)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &gt;600 vs &lt;200</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">2.19 (0.77-6.24)</td><td valign="top" align="left" rowspan="1" colspan="1">.14</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: AOR, adjusted odds ratio; CT, computed tomography; EMS, emergency medical services; NA, not applicable; NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio.</p><fn id="zoi250960t3n1"><label>
<sup>a</sup>
</label><p>Model 2 adjusted for patient characteristics, which included the following covariates: age, sex, race and ethnicity, medical history variables, last known well to arrival time, presence of large vessel occlusion, NIHSS, arrival method, off-hours arrival, door-to-CT time, and transfer status.</p></fn><fn id="zoi250960t3n2"><label>
<sup>b</sup>
</label><p>Model 3 included adjustments for the patient characteristics and hospital characteristics, including metropolitan status, teaching hospital status, presence of a neurology residency program, stroke center certification status, and annual number of acute stroke discharges.</p></fn><fn id="zoi250960t3n3"><label>
<sup>c</sup>
</label><p>Other race and ethnicity included Asian, American Indian or Alaska Native, Native Hawaiian or Pacific Islander, or unable to determine.</p></fn><fn id="zoi250960t3n4"><label>
<sup>d</sup>
</label><p>Scale of 0 to 42, with higher values indicating greater severity of stroke.</p></fn><fn id="zoi250960t3n5"><label>
<sup>e</sup>
</label><p>Regular (nonholiday) hours were 7:00 <sc>am</sc> to 6:00 <sc>pm</sc>, Monday through Friday.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="zoi250960t4" orientation="portrait"><label>Table 4. </label><caption><title>Multilevel Model of DTN Time by Telestroke Activation, With and Without Adjustment for Patient and Hospital Characteristics (n&#8201;=&#8201;1673)</title></caption><table frame="hsides" rules="groups"><col width="24.17%" span="1"/><col width="13.99%" span="1"/><col width="8.71%" span="1"/><col width="15.82%" span="1"/><col width="9.14%" span="1"/><col width="18.19%" span="1"/><col width="9.98%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="rowgroup" colspan="1">Coefficient</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Model 1: unadjusted</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Model 2: adjusted for patient characteristics<xref rid="zoi250960t4n1" ref-type="table-fn"><sup>a</sup></xref></th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Model 3: further adjusted for patient and hospital characteristics<xref rid="zoi250960t4n2" ref-type="table-fn"><sup>b</sup></xref></th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Estimate (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Estimate (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Estimate (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Initial DTN time, min</td><td valign="top" align="left" rowspan="1" colspan="1">54.15 (50.17 to 58.14)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">77.96 (69.14 to 86.79)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">69.53 (52.27 to 86.80)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Telestroke activation, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">9.10 (4.18 to 14.02)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">7.44 (2.97 to 11.90)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td><td valign="top" align="left" rowspan="1" colspan="1">6.55 (2.12 to 10.97)</td><td valign="top" align="left" rowspan="1" colspan="1">.003</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, per 1-y increase</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.01 (&#8722;0.09 to 0.11)</td><td valign="top" align="left" rowspan="1" colspan="1">.79</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (&#8722;0.08 to 0.12)</td><td valign="top" align="left" rowspan="1" colspan="1">.67</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sex, female vs male</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">2.84 (0.30 to 5.39)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td><td valign="top" align="left" rowspan="1" colspan="1">2.72 (0.18 to 5.26)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Race and ethnicity (reference group, White)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Black</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;2.73 (&#8722;6.85 to 1.39)</td><td valign="top" align="left" rowspan="1" colspan="1">.19</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;2.85 (&#8722;6.93 to 1.23)</td><td valign="top" align="left" rowspan="1" colspan="1">.17</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hispanic</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">5.93 (&#8722;3.06 to 14.92)</td><td valign="top" align="left" rowspan="1" colspan="1">.19</td><td valign="top" align="left" rowspan="1" colspan="1">5.63 (&#8722;3.33 to 14.60)</td><td valign="top" align="left" rowspan="1" colspan="1">.21</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other<xref rid="zoi250960t4n3" ref-type="table-fn"><sup>c</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;2.31 (&#8722;8.29 to 3.66)</td><td valign="top" align="left" rowspan="1" colspan="1">.44</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;2.14 (&#8722;8.10 to 3.82)</td><td valign="top" align="left" rowspan="1" colspan="1">.48</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of atrial fibrillation, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.51 (&#8722;4.36 to 3.34)</td><td valign="top" align="left" rowspan="1" colspan="1">.79</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.54 (&#8722;4.38 to 3.30)</td><td valign="top" align="left" rowspan="1" colspan="1">.78</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of stroke, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">2.15 (&#8722;0.70 to 4.99)</td><td valign="top" align="left" rowspan="1" colspan="1">.13</td><td valign="top" align="left" rowspan="1" colspan="1">2.06 (&#8722;0.78 to 4.89)</td><td valign="top" align="left" rowspan="1" colspan="1">.15</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of heart failure, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">3.33 (&#8722;0.93 to 7.59)</td><td valign="top" align="left" rowspan="1" colspan="1">.12</td><td valign="top" align="left" rowspan="1" colspan="1">3.03 (&#8722;1.22 to 7.27)</td><td valign="top" align="left" rowspan="1" colspan="1">.16</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of diabetes, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.04 (&#8722;3.90 to 1.82)</td><td valign="top" align="left" rowspan="1" colspan="1">.47</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.14 (&#8722;3.99 to 1.71)</td><td valign="top" align="left" rowspan="1" colspan="1">.43</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of hypertension, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.32 (&#8722;3.41 to 2.77)</td><td valign="top" align="left" rowspan="1" colspan="1">.83</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.50 (&#8722;3.59 to 2.58)</td><td valign="top" align="left" rowspan="1" colspan="1">.74</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of cigarette smoking, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.85 (&#8722;5.17 to 1.46)</td><td valign="top" align="left" rowspan="1" colspan="1">.27</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;2.32 (&#8722;5.64 to 0.99)</td><td valign="top" align="left" rowspan="1" colspan="1">.16</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Last known well to arrival time, per 1-min increase</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.04 (&#8722;0.06 to &#8722;0.02)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.04 (&#8722;0.07 to &#8722;0.02)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Large vessel occlusion, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;4.62 (&#8722;7.81 to &#8722;1.43)</td><td valign="top" align="left" rowspan="1" colspan="1">.004</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;4.13 (&#8722;7.33 to &#8722;0.93)</td><td valign="top" align="left" rowspan="1" colspan="1">.011</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">NIHSS category<xref rid="zoi250960t4n4" ref-type="table-fn"><sup>d</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 5-15 vs 0-4 points</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;8.29 (&#8722;11.22 to &#8722;5.37)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;8.30 (&#8722;11.22 to &#8722;5.39)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 16-20 vs 0-4 points</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;2.16 (&#8722;7.28 to 2.97)</td><td valign="top" align="left" rowspan="1" colspan="1">.40</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.92 (&#8722;7.03 to 3.19)</td><td valign="top" align="left" rowspan="1" colspan="1">.46</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 21-42 vs 0-4 points</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;8.34 (&#8722;13.39 to &#8722;3.28)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;8.15 (&#8722;13.19 to &#8722;3.11)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Arrival method</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> EMS no prenotification vs private transportation</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.59 (&#8722;4.42 to 3.25)</td><td valign="top" align="left" rowspan="1" colspan="1">.76</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.33 (&#8722;4.14 to 3.48)</td><td valign="top" align="left" rowspan="1" colspan="1">.86</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> EMS prenotification vs private transportation</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.47 (&#8722;4.90 to 1.97)</td><td valign="top" align="left" rowspan="1" colspan="1">.40</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.10 (&#8722;4.52 to 2.32)</td><td valign="top" align="left" rowspan="1" colspan="1">.52</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Off-hours arrival, yes vs no<xref rid="zoi250960t4n5" ref-type="table-fn"><sup>e</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">2.99 (0.46 to 5.51)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td><td valign="top" align="left" rowspan="1" colspan="1">3.04 (0.52 to 5.56)</td><td valign="top" align="left" rowspan="1" colspan="1">.017</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Door-to-CT time &#8804;20 min, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;25.67 (&#8722;29.04 to &#8722;22.31)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;25.75 (&#8722;29.10 to &#8722;22.40)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Transfer to another hospital, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">8.80 (1.83 to 15.78)</td><td valign="top" align="left" rowspan="1" colspan="1">.013</td><td valign="top" align="left" rowspan="1" colspan="1">5.18 (&#8722;2.27 to 12.63)</td><td valign="top" align="left" rowspan="1" colspan="1">.17</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Metropolitan hospital, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.84 (&#8722;7.25 to 10.93)</td><td valign="top" align="left" rowspan="1" colspan="1">.69</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Teaching hospital, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">10.04 (2.48 to 17.60)</td><td valign="top" align="left" rowspan="1" colspan="1">.009</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Neurology residency program, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">3.09 (&#8722;2.62 to 8.80)</td><td valign="top" align="left" rowspan="1" colspan="1">.28</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Stroke center status</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Thrombectomy-capable vs comprehensive</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">14.30 (5.46 to 23.13)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Primary vs comprehensive</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">11.11 (5.12 to 17.09)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Not certified vs comprehensive</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">24.59 (1.52 to 47.65)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Annual No. of acute stroke discharges</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 200-600 vs &lt;200</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;12.38 (&#8722;23.04 to &#8722;1.73)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &gt;600 vs &lt;200</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;7.46 (&#8722;19.20 to 4.29)</td><td valign="top" align="left" rowspan="1" colspan="1">.21</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: CT, computed tomography; DTN, door-to-needle; EMS, emergency medical services; NA, not applicable; NIHSS, National Institutes of Health Stroke Scale.</p><fn id="zoi250960t4n1"><label>
<sup>a</sup>
</label><p>Model 2 adjusted for patient characteristics, which included the following covariates: age, sex, race and ethnicity, medical history variables, last known well to arrival time, presence of large vessel occlusion, NIHSS, arrival method, off-hours arrival, door-to-CT time, and transfer status.</p></fn><fn id="zoi250960t4n2"><label>
<sup>b</sup>
</label><p>Model 3 included adjustments for the patient characteristics and hospital characteristics, including metropolitan status, teaching hospital status, presence of a neurology residency program, stroke center certification status, and annual number of acute stroke discharges.</p></fn><fn id="zoi250960t4n3"><label>
<sup>c</sup>
</label><p>Other race and ethnicity included Asian, American Indian or Alaska Native, Native Hawaiian or Pacific Islander, or unable to determine.</p></fn><fn id="zoi250960t4n4"><label>
<sup>d</sup>
</label><p>Scale of 0 to 42, with higher values indicating greater severity of stroke.</p></fn><fn id="zoi250960t4n5"><label>
<sup>e</sup>
</label><p>Regular (nonholiday) hours were 7:00 <sc>am</sc> to 6:00 <sc>pm</sc>, Monday through Friday.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="zoi250960t5" orientation="portrait"><label>Table 5. </label><caption><title>Multilevel Model of Guideline-Concordant Door-to-Needle Time Within 60 Minutes by Telestroke Activation, With and Without Adjustment for Patient and Hospital Characteristics (n&#8201;=&#8201;1673)</title></caption><table frame="hsides" rules="groups"><col width="22.78%" span="1"/><col width="15.77%" span="1"/><col width="9.38%" span="1"/><col width="15.64%" span="1"/><col width="10.42%" span="1"/><col width="15.64%" span="1"/><col width="10.37%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="rowgroup" colspan="1">Coefficient</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Model 1: unadjusted</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Model 2: adjusted for patient characteristics<xref rid="zoi250960t5n1" ref-type="table-fn"><sup>a</sup></xref></th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Model 3: further adjusted for patient and hospital characteristics<xref rid="zoi250960t5n2" ref-type="table-fn"><sup>b</sup></xref></th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">OR (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">AOR (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">AOR (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Telestroke activation, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">0.52 (0.36-0.74)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.51 (0.35-0.76)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.56 (0.39-0.81)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, per 1-y increase</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.00 (0.99-1.01)</td><td valign="top" align="left" rowspan="1" colspan="1">.70</td><td valign="top" align="left" rowspan="1" colspan="1">1.00 (0.99-1.01)</td><td valign="top" align="left" rowspan="1" colspan="1">.91</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sex, female vs male</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.82 (0.64-1.05)</td><td valign="top" align="left" rowspan="1" colspan="1">.11</td><td valign="top" align="left" rowspan="1" colspan="1">0.83 (0.65-1.06)</td><td valign="top" align="left" rowspan="1" colspan="1">.14</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Race and ethnicity</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Black vs White</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.09 (0.74-1.61)</td><td valign="top" align="left" rowspan="1" colspan="1">.65</td><td valign="top" align="left" rowspan="1" colspan="1">1.10 (0.75-1.61)</td><td valign="top" align="left" rowspan="1" colspan="1">.62</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hispanic vs White</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.56 (0.24-1.30)</td><td valign="top" align="left" rowspan="1" colspan="1">.17</td><td valign="top" align="left" rowspan="1" colspan="1">0.58 (0.25-1.34)</td><td valign="top" align="left" rowspan="1" colspan="1">.20</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other vs White<xref rid="zoi250960t5n3" ref-type="table-fn"><sup>c</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.91 (0.51-1.61)</td><td valign="top" align="left" rowspan="1" colspan="1">.74</td><td valign="top" align="left" rowspan="1" colspan="1">0.87 (0.50-1.54)</td><td valign="top" align="left" rowspan="1" colspan="1">.64</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of atrial fibrillation, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.89 (0.62-1.28)</td><td valign="top" align="left" rowspan="1" colspan="1">.54</td><td valign="top" align="left" rowspan="1" colspan="1">0.89 (0.62-1.28)</td><td valign="top" align="left" rowspan="1" colspan="1">.53</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of stroke, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.82 (0.63-1.07)</td><td valign="top" align="left" rowspan="1" colspan="1">.15</td><td valign="top" align="left" rowspan="1" colspan="1">0.83 (0.64-1.08)</td><td valign="top" align="left" rowspan="1" colspan="1">.16</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of heart failure, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.76 (0.51-1.14)</td><td valign="top" align="left" rowspan="1" colspan="1">.18</td><td valign="top" align="left" rowspan="1" colspan="1">0.79 (0.53-1.18)</td><td valign="top" align="left" rowspan="1" colspan="1">.24</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of diabetes, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.18 (0.90-1.56)</td><td valign="top" align="left" rowspan="1" colspan="1">.23</td><td valign="top" align="left" rowspan="1" colspan="1">1.20 (0.91-1.58)</td><td valign="top" align="left" rowspan="1" colspan="1">.19</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of hypertension, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.04 (0.77-1.39)</td><td valign="top" align="left" rowspan="1" colspan="1">.80</td><td valign="top" align="left" rowspan="1" colspan="1">1.06 (0.79-1.43)</td><td valign="top" align="left" rowspan="1" colspan="1">.68</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of cigarette smoking, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.08 (0.79-1.48)</td><td valign="top" align="left" rowspan="1" colspan="1">.63</td><td valign="top" align="left" rowspan="1" colspan="1">1.13 (0.83-1.55)</td><td valign="top" align="left" rowspan="1" colspan="1">.44</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Last known well to arrival time, per 1-min increase</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.00 (1.00-1.01)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">1.00 (1.00-1.01)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Large vessel occlusion, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.34 (0.98-1.83)</td><td valign="top" align="left" rowspan="1" colspan="1">.07</td><td valign="top" align="left" rowspan="1" colspan="1">1.26 (0.92-1.73)</td><td valign="top" align="left" rowspan="1" colspan="1">.15</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">NIHSS category<xref rid="zoi250960t5n4" ref-type="table-fn"><sup>d</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 5-15 vs 0-4 points</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.73 (1.31-2.29)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">1.75 (1.33-2.31)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 16-20 vs 0-4 points</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.33 (0.81-2.19)</td><td valign="top" align="left" rowspan="1" colspan="1">.25</td><td valign="top" align="left" rowspan="1" colspan="1">1.31 (0.80-2.15)</td><td valign="top" align="left" rowspan="1" colspan="1">.28</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 21-42 vs 0-4 points</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.60 (0.98-2.60)</td><td valign="top" align="left" rowspan="1" colspan="1">.058</td><td valign="top" align="left" rowspan="1" colspan="1">1.59 (0.98-2.59)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Arrival method</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> EMS no prenotification vs private transportation</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.93 (0.66-1.31)</td><td valign="top" align="left" rowspan="1" colspan="1">.67</td><td valign="top" align="left" rowspan="1" colspan="1">0.89 (0.63-1.25)</td><td valign="top" align="left" rowspan="1" colspan="1">.49</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> EMS prenotification vs private transportation</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.16 (0.84-1.59)</td><td valign="top" align="left" rowspan="1" colspan="1">.36</td><td valign="top" align="left" rowspan="1" colspan="1">1.11 (0.81-1.53)</td><td valign="top" align="left" rowspan="1" colspan="1">.51</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Off-hours arrival, yes vs no<xref rid="zoi250960t5n5" ref-type="table-fn"><sup>e</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.87 (0.69-1.11)</td><td valign="top" align="left" rowspan="1" colspan="1">.26</td><td valign="top" align="left" rowspan="1" colspan="1">0.87 (0.68-1.11)</td><td valign="top" align="left" rowspan="1" colspan="1">.25</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Door-to-CT time &#8804;20 min, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">7.26 (5.36-9.83)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td><td valign="top" align="left" rowspan="1" colspan="1">7.34 (5.44-9.92)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Transfer to another hospital, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.58 (0.31-1.09)</td><td valign="top" align="left" rowspan="1" colspan="1">.09</td><td valign="top" align="left" rowspan="1" colspan="1">0.90 (0.45-1.77)</td><td valign="top" align="left" rowspan="1" colspan="1">.75</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Metropolitan hospital, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.91 (0.48-1.76)</td><td valign="top" align="left" rowspan="1" colspan="1">.78</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Teaching hospital, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.51 (0.30-0.88)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Neurology residency program, yes vs no</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.88 (0.58-1.35)</td><td valign="top" align="left" rowspan="1" colspan="1">.56</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Stroke center status</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Thrombectomy-capable vs comprehensive</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.38 (0.20-0.72)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Primary vs comprehensive</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.39 (0.25-0.61)</td><td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Not certified vs comprehensive</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.08 (0.01-0.59)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Annual No. of acute stroke discharges</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 200-600 vs &lt;200</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">2.22 (0.99-4.97)</td><td valign="top" align="left" rowspan="1" colspan="1">.054</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &gt;600 vs &lt;200</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.37 (0.57-3.32)</td><td valign="top" align="left" rowspan="1" colspan="1">.48</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: AOR, adjusted odds ratio; CT, computed tomography; EMS, emergency medical services; NA, not applicable; NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio.</p><fn id="zoi250960t5n1"><label>
<sup>a</sup>
</label><p>Model 2 adjusted for patient characteristics, which included the following covariates: age, sex, race and ethnicity, medical history variables, last known well to arrival time, presence of large vessel occlusion, NIHSS, arrival method, off-hours arrival, door-to-CT time, and transfer status.</p></fn><fn id="zoi250960t5n2"><label>
<sup>b</sup>
</label><p>Model 3 included adjustments for the patient characteristics and hospital characteristics, including metropolitan status, teaching hospital status, presence of a neurology residency program, stroke center certification status, and annual number of acute stroke discharges.</p></fn><fn id="zoi250960t5n3"><label>
<sup>c</sup>
</label><p>Other race and ethnicity included Asian, American Indian or Alaska Native, Native Hawaiian or Pacific Islander, or unable to determine.</p></fn><fn id="zoi250960t5n4"><label>
<sup>d</sup>
</label><p>Scale of 0 to 42, with higher values indicating greater severity of stroke.</p></fn><fn id="zoi250960t5n5"><label>
<sup>e</sup>
</label><p>Regular (nonholiday) hours were 7:00 <sc>am</sc> to 6:00 <sc>pm</sc>, Monday through Friday.</p></fn></table-wrap-foot></table-wrap><p>After adjustment for patient and hospital characteristics, telestroke treatment was not associated with being discharged home, independent ambulation at discharge, or receiving DTN within 45 minutes (eTables 2-4 in <xref rid="note-ZOI250960-1-s" ref-type="supplementary-material">Supplement 1</xref>). Among 255 patients who underwent interhospital transfer (207 patients received thrombolysis), telestroke was associated with significantly longer DIDO times (46.90 minutes longer; 95% CI, 1.08-92.72 minutes longer; <italic toggle="yes">P</italic>&#8201;=&#8201;.04) (eTable 5 in <xref rid="note-ZOI250960-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><p>The sensitivity analysis that removed transferred patients produced similar results to the primary analysis (eTables 6-8 in <xref rid="note-ZOI250960-1-s" ref-type="supplementary-material">Supplement 1</xref>). A comparison of patients with nonmissing vs missing telestroke activation status showed significant differences in several baseline and hospital-level characteristics (eTable 9 in <xref rid="note-ZOI250960-1-s" ref-type="supplementary-material">Supplement 1</xref>), yet a sensitivity analysis that imputed missing values for telestroke activation to no yielded overall similar results to the primary analyses (eTables 10-12 in <xref rid="note-ZOI250960-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p></sec><sec id="H1-4-ZOI250960"><title>Discussion</title><p>This cohort study of patients with AIS potentially eligible for thrombolysis found that those evaluated by telestroke were more likely to receive thrombolysis but had significantly prolonged DTN times compared with those not evaluated by telestroke. Namely, patients evaluated by telestroke had a 44% lower odds of meeting guideline-concordant DTN times within 60 minutes compared with those who were not treated by telestroke. These differences were partially attenuated by patient-level and hospital-level characteristics but remained statistically significant in fully adjusted models. Among transferred patients, telestroke was associated with significantly prolonged (47 minutes longer) DIDO transfer times.</p><p>Prior literature comparing stroke treatment times via telestroke and standard, in-person stroke care has consisted of analyses of single medical systems. A 2011 study from the University of Pittsburgh found prolonged DTN times in patients evaluated by telestroke at spoke hospitals compared with those treated at academic hub hospitals.<sup><xref rid="zoi250960r11" ref-type="bibr">11</xref></sup> Another analysis from 2017 found significantly prolonged DTN times for patients treated with telestroke compared with hub-treated patients and concluded that time from emergency department arrival to telestroke consultation request was the largest barrier to timely DTN times in the single telestroke network.<sup><xref rid="zoi250960r14" ref-type="bibr">14</xref></sup> A 2018 publication from the Mayo Clinic system found prolonged time metrics in patients treated with telestroke at spoke hospitals compared with hub hospitals, with longer times to stroke alert activation, stroke team examination, and time to treatment via telestroke.<sup><xref rid="zoi250960r12" ref-type="bibr">12</xref></sup> The current study substantially expands this prior work by studying 42 hospitals in the Paul Coverdell Michigan registry and controlling for patient- and hospital-level confounders.</p><p>Our finding that patients evaluated by telestroke had a 44% lower odds of achieving guideline-concordant DTN times is important because treatment for AIS is very time-sensitive,<sup><xref rid="zoi250960r1" ref-type="bibr">1</xref>,<xref rid="zoi250960r3" ref-type="bibr">3</xref></sup> and delays put patients at risk for increased disability and mortality. Substantial national resources and efforts have been expended to improve DTN times. In 2010, the AHA initiated the Target: Stroke program to improve DTN times nationally and to improve stroke care and outcomes.<sup><xref rid="zoi250960r4" ref-type="bibr">4</xref></sup> A 2014 study evaluating Target: Stroke implementation found that hospitals participating in the initiative reduced their average DTN times from 74 to 59 minutes. Patients with stroke treated within 60 minutes had improved outcomes, including reduced long-term disability and in-hospital mortality.<sup><xref rid="zoi250960r6" ref-type="bibr">6</xref></sup> Given the success of Target: Stroke Phase I, the AHA and American Stroke Association commenced Target: Stroke Phase II in 2015, raising the goal for 75% of eligible patients with ischemic stroke to be treated within 60 minutes. In Target: Stroke Phase III, the bar was raised even higher, with a goal of 85% of patients being treated within 60 minutes.<sup><xref rid="zoi250960r7" ref-type="bibr">7</xref></sup> By contrast, our study found that from 2022 to 2023, only 60% of patients evaluated by telestroke received thrombolysis within 60 minutes. This finding represents a major opportunity for ongoing quality improvement, and improving these treatment times will require an understanding of the unique factors in telestroke systems that contribute to treatment delays.</p><p>In this study, patients evaluated by telestroke had a higher odds of receiving thrombolysis compared with those who were not. A challenge of interpreting this result is the potential selection bias that patients for whom a telestroke consultation was placed may have been inherently more likely to be candidates for acute stroke treatment, even though the same selection criteria were applied to both telestroke and nontelestroke cases. Acknowledging this potential bias, the higher thrombolytic use by telestroke in this study is consistent with a prior study using administrative claims data, which found a higher use of thrombolysis in patients receiving telestroke vs usual care (not telestroke).<sup><xref rid="zoi250960r8" ref-type="bibr">8</xref></sup> The strength of our study using stroke registry data was the adjustment for highly detailed patient-level (eg, stroke severity as measured by NIHSS) and hospital-level confounders (eg, Joint Commission stroke center certification status), which are not captured in claims data.</p><p>Prior literature, which has largely focused on in-person&#8211;assessed AIS cases, demonstrated that EMS prenotification is associated with faster DTN times,<sup><xref rid="zoi250960r21" ref-type="bibr">21</xref></sup> yet this was not the case in our study. Emergency medical service prenotification to telestroke spoke sites does not standardly alert telestroke-providing neurologists at the hub site.<sup><xref rid="zoi250960r14" ref-type="bibr">14</xref></sup> Thus, EMS prenotification may not yield the same time-treatment benefit for telestroke in its present form. Future studies should explore the role of EMS prenotification in telestroke systems to optimize this important systems factor.</p><p>Patients evaluated by telestroke had a significantly prolonged DIDO time (46.9 minutes longer) compared with those who were not, after accounting for clustering by hospital site and adjusting for patient-level covariates. Particularly in the era of endovascular thrombectomy, DIDO time has become an important stroke quality metric, with current recommendations for times within 120 minutes for all stroke transfers<sup><xref rid="zoi250960r25" ref-type="bibr">25</xref></sup> and within 90 minutes for potential candidates for endovascular thrombectomy.<sup><xref rid="zoi250960r26" ref-type="bibr">26</xref></sup> Prior work using the national Get With The Guidelines&#8211;Stroke registry found that DIDO times were significantly prolonged compared with these recommended targets, with an overall median DIDO time of 174 minutes for all stroke transfers.<sup><xref rid="zoi250960r27" ref-type="bibr">27</xref></sup> The current study found DIDO times comparable to this prior work (166 minutes for telestroke, 150 minutes for nontelestroke), but prior studies have not compared DIDO time by telestroke status. Our findings highlight that DIDO times were particularly prolonged via telestroke. A prior qualitative analysis within an academic telestroke network identified several barriers to timely transfer, including lack of EMS availability and difficulty finding an accepting facility.<sup><xref rid="zoi250960r28" ref-type="bibr">28</xref></sup> Future work should test these findings in other and larger samples and evaluate for additional telestroke-specific factors that may contribute to prolonged DIDO times.</p><p>In the bivariate comparisons, patients evaluated by telestroke were less likely to ambulate independently at hospital discharge and less likely to be discharged home than those who were not. The directions of the associations were maintained in the hierarchical multivariable models, but they lost statistical significance. A prior study published in 2018 from the Mayo Clinic Telestroke Program compared evidence-based stroke discharge outcomes between hub-and-spoke hospital&#8211;treated patients and found worse functional outcomes at hospital discharge among telestroke spoke&#8211;treated patients.<sup><xref rid="zoi250960r12" ref-type="bibr">12</xref></sup> However, this prior study only used bivariate comparisons without multivariable adjustment for patient- and hospital-level characteristics. Our findings suggest that patient and hospital characteristics contribute to the observed association between telestroke and these outcomes.</p><sec id="H2-6-ZOI250960"><title>Limitations</title><p>This study has several limitations. First, the study was based on stroke registry results from a single state. Results may differ if further examined in other states or in a national sample. Nonetheless, the Paul Coverdell Michigan Stroke Registry comprises a wide range of participating hospital types and overall accounts for approximately 64% of strokes in Michigan statewide.<sup><xref rid="zoi250960r29" ref-type="bibr">29</xref></sup> Second, the telestroke variable used as the primary exposure started routinely being collected in the Paul Coverdell Michigan Stroke Registry in 2022, and it had a high overall rate of missingness that may have been due to the recent introduction and less familiarity with this variable among registry abstractors. Still, the use of a telestroke-specific variable represents an important advance as prior large-scale telestroke literature has focused on telestroke capacity at the hospital level<sup><xref rid="zoi250960r30" ref-type="bibr">30</xref></sup> rather than on patient-level documentation of a telestroke encounter. Third, the nontelestroke comparison group in the primary analysis was a heterogeneous group of patients presenting to a variety of stroke center types (<xref rid="zoi250960t1" ref-type="table">Table 1</xref>). However, with the hierarchical modeling approach, we observed that only 12% of the variation of receipt of thrombolysis and 10% of the variation in DTN time outcomes were associated with differences between hospitals. Fourth, secondary outcomes included metrics of functional ability, eg, mRS scores and ambulatory status, but these were measured at hospital discharge and not at 90-day follow-up, which is the standard follow-up time frame in many acute stroke treatment trials.<sup><xref rid="zoi250960r31" ref-type="bibr">31</xref></sup> Yet, discharge mRS scores have been found to accurately estimate 90-day mRS scores.<sup><xref rid="zoi250960r32" ref-type="bibr">32</xref></sup> Fifth, there were relatively few treated patients transferred to another hospital within the sample (which may have been due to the study&#8217;s selection criteria of eligibility for thrombolytic therapy), limiting the power of the DIDO outcome analysis. Though hospital cluster effects were accounted for via the hierarchical modeling in this study, we were unable to include hospital-level covariates in the DIDO outcome model due to limited degrees of freedom. Comparison of DIDO times by telestroke status represents an important first evaluation in this field but should be confirmed in larger datasets evaluating interhospital transfer. Finally, given the observational study design comparing different patients from different hospitals, even robust adjustment may leave residual confounding, and this study estimates associations rather than causal effects.</p></sec></sec><sec id="H1-5-ZOI250960"><title>Conclusions</title><p>This state registry&#8211;based cohort study of patients with AIS potentially eligible for thrombolysis found that patients evaluated by telestroke had a higher odds of receiving thrombolysis but significantly prolonged DTN and DIDO times and a lower odds of meeting guideline-concordant DTN times within 60 minutes compared with patients not evaluated by telestroke. Telestroke has the potential to revolutionize acute stroke treatment by improving access to stroke care, including increased use of thrombolysis, yet these findings suggest that there is room to improve DTN and transfer times for patients evaluated by telestroke to ensure that all patients with ischemic stroke receive guideline-concordant, time-sensitive care.</p></sec></body><back><ref-list id="REF-ZOI250960"><title>References</title><ref id="zoi250960r1"><label>1</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Saver</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Fonarow</surname><given-names>GC</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>EE</given-names></string-name>, <etal/></person-group>. <article-title>Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke</article-title>. <source>JAMA</source>. <year>2013</year>;<volume>309</volume>(<issue>23</issue>):<fpage>2480</fpage>-<lpage>2488</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2013.6959</pub-id><pub-id pub-id-type="pmid">23780461</pub-id></mixed-citation></ref><ref id="zoi250960r2"><label>2</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Saver</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Goyal</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>van der Lugt</surname><given-names>A</given-names></string-name>, <etal/>; <collab>HERMES Collaborators</collab></person-group>. <article-title>Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis</article-title>. <source>JAMA</source>. <year>2016</year>;<volume>316</volume>(<issue>12</issue>):<fpage>1279</fpage>-<lpage>1288</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2016.13647</pub-id><pub-id pub-id-type="pmid">27673305</pub-id></mixed-citation></ref><ref id="zoi250960r3"><label>3</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Saver</surname><given-names>JL</given-names></string-name></person-group>. <article-title>Time is brain&#8211;quantified</article-title>. <source>Stroke</source>. <year>2006</year>;<volume>37</volume>(<issue>1</issue>):<fpage>263</fpage>-<lpage>266</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.STR.0000196957.55928.ab</pub-id><pub-id pub-id-type="pmid">16339467</pub-id></mixed-citation></ref><ref id="zoi250960r4"><label>4</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Fonarow</surname><given-names>GC</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Saver</surname><given-names>JL</given-names></string-name>, <etal/></person-group>. <article-title>Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association&#8217;s Target: Stroke initiative</article-title>. <source>Stroke</source>. <year>2011</year>;<volume>42</volume>(<issue>10</issue>):<fpage>2983</fpage>-<lpage>2989</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.111.621342</pub-id><pub-id pub-id-type="pmid">21885841</pub-id></mixed-citation></ref><ref id="zoi250960r5"><label>5</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Man</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Xian</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Holmes</surname><given-names>DN</given-names></string-name>, <etal/></person-group>. <article-title>Target: Stroke was associated with faster intravenous thrombolysis and improved one-year outcomes for acute ischemic stroke in Medicare beneficiaries</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>. <year>2020</year>;<volume>13</volume>(<issue>12</issue>):<elocation-id>e007150</elocation-id>. doi:<pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.120.007150</pub-id><pub-id pub-id-type="pmid">33302714</pub-id></mixed-citation></ref><ref id="zoi250960r6"><label>6</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Fonarow</surname><given-names>GC</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>EE</given-names></string-name>, <etal/></person-group>. <article-title>Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative</article-title>. <source>JAMA</source>. <year>2014</year>;<volume>311</volume>(<issue>16</issue>):<fpage>1632</fpage>-<lpage>1640</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2014.3203</pub-id><pub-id pub-id-type="pmid">24756513</pub-id></mixed-citation></ref><ref id="zoi250960r7"><label>7</label><mixed-citation publication-type="webpage">American Heart Association. Phase III Target: Stroke. American Stroke Association. Accessed July 14, 2025. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.stroke.org/-/media/files/professional/quality-improvement/target-stroke/target-stroke-phase-iii/aha-qi-target-stroke-phase-3-brochure.pdf" ext-link-type="uri">https://www.stroke.org/-/media/files/professional/quality-improvement/target-stroke/target-stroke-phase-iii/aha-qi-target-stroke-phase-3-brochure.pdf</ext-link></mixed-citation></ref><ref id="zoi250960r8"><label>8</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Zhang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>W</given-names></string-name>, <etal/></person-group>. <article-title>Expansion of telestroke services improves quality of care provided in super rural areas</article-title>. <source>Health Aff (Millwood)</source>. <year>2018</year>;<volume>37</volume>(<issue>12</issue>):<fpage>2005</fpage>-<lpage>2013</lpage>. doi:<pub-id pub-id-type="doi">10.1377/hlthaff.2018.05089</pub-id><pub-id pub-id-type="pmid">30633675</pub-id></mixed-citation></ref><ref id="zoi250960r9"><label>9</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Tumma</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Berzou</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Jaques</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Shah</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Thomas</surname><given-names>EE</given-names></string-name></person-group>. <article-title>Considerations for the implementation of a telestroke network: a systematic review</article-title>. <source>J Stroke Cerebrovasc Dis</source>. <year>2022</year>;<volume>31</volume>(<issue>1</issue>):<elocation-id>106171</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2021.106171</pub-id><pub-id pub-id-type="pmid">34735902</pub-id></mixed-citation></ref><ref id="zoi250960r10"><label>10</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Wechsler</surname><given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Demaerschalk</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Schwamm</surname><given-names>LH</given-names></string-name>, <etal/>; <collab>American Heart Association Stroke Council</collab>; <collab>Council on Epidemiology and Prevention</collab>; <collab>Council on Quality of Care and Outcomes Research</collab></person-group>. <article-title>Telemedicine quality and outcomes in stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association</article-title>. <source>Stroke</source>. <year>2017</year>;<volume>48</volume>(<issue>1</issue>):<fpage>e3</fpage>-<lpage>e25</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STR.0000000000000114</pub-id><pub-id pub-id-type="pmid">27811332</pub-id></mixed-citation></ref><ref id="zoi250960r11"><label>11</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Zaidi</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Jumma</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Urra</surname><given-names>XN</given-names></string-name>, <etal/></person-group>. <article-title>Telestroke-guided intravenous tissue-type plasminogen activator treatment achieves a similar clinical outcome as thrombolysis at a comprehensive stroke center</article-title>. <source>Stroke</source>. <year>2011</year>;<volume>42</volume>(<issue>11</issue>):<fpage>3291</fpage>-<lpage>3293</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.111.625046</pub-id><pub-id pub-id-type="pmid">21885843</pub-id></mixed-citation></ref><ref id="zoi250960r12"><label>12</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Demaerschalk</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Boyd</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Barrett</surname><given-names>KM</given-names></string-name>, <etal/></person-group>. <article-title>Comparison of stroke outcomes of hub and spoke hospital treated patients in Mayo Clinic telestroke program</article-title>. <source>J Stroke Cerebrovasc Dis</source>. <year>2018</year>;<volume>27</volume>(<issue>11</issue>):<fpage>2940</fpage>-<lpage>2942</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2018.06.024</pub-id><pub-id pub-id-type="pmid">30146388</pub-id></mixed-citation></ref><ref id="zoi250960r13"><label>13</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Al Kasab</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Harvey</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Debenham</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Turner</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Holmstedt</surname><given-names>CA</given-names></string-name></person-group>. <article-title>Door to needle time over telestroke-a comprehensive stroke center experience</article-title>. <source>Telemed J E Health</source>. <year>2018</year>;<volume>24</volume>(<issue>2</issue>):<fpage>111</fpage>-<lpage>115</lpage>. doi:<pub-id pub-id-type="doi">10.1089/tmj.2017.0067</pub-id><pub-id pub-id-type="pmid">28753069</pub-id></mixed-citation></ref><ref id="zoi250960r14"><label>14</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Asaithambi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Castle</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Sperl</surname><given-names>MA</given-names></string-name>, <etal/></person-group>. <article-title>The door to needle time metric can be achieved via telestroke</article-title>. <source>Neurohospitalist</source>. <year>2017</year>;<volume>7</volume>(<issue>4</issue>):<fpage>188</fpage>-<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1941874417704753</pub-id><pub-id pub-id-type="pmid">28974997</pub-id><pub-id pub-id-type="pmcid">PMC5613871</pub-id></mixed-citation></ref><ref id="zoi250960r15"><label>15</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Loggini</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hornik</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Henson</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wesler</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Nelson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hornik</surname><given-names>A</given-names></string-name></person-group>. <article-title>Target door-to-needle time in acute stroke treatment via telemedicine versus in-person evaluation in a rural setting of the Midwest: a retrospective cohort study</article-title>. <source>J Stroke Cerebrovasc Dis</source>. <year>2025</year>;<volume>34</volume>(<issue>1</issue>):<elocation-id>108141</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2024.108141</pub-id><pub-id pub-id-type="pmid">39557182</pub-id></mixed-citation></ref><ref id="zoi250960r16"><label>16</label><mixed-citation publication-type="webpage">Paul Coverdell National Acute Stroke Program. Centers for Disease Control and Prevention. Accessed August 23, 2025. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/coverdell/?CDC_AAref_Val" ext-link-type="uri">https://www.cdc.gov/coverdell/?CDC_AAref_Val</ext-link></mixed-citation></ref><ref id="zoi250960r17"><label>17</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>von Elm</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Altman</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Egger</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Pocock</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>G&#248;tzsche</surname><given-names>PC</given-names></string-name>, <string-name name-style="western"><surname>Vandenbroucke</surname><given-names>JP</given-names></string-name>; <collab>STROBE Initiative</collab></person-group>. <article-title>Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title>. <source>BMJ</source>. <year>2007</year>;<volume>335</volume>(<issue>7624</issue>):<fpage>806</fpage>-<lpage>808</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.39335.541782.AD</pub-id><pub-id pub-id-type="pmid">17947786</pub-id><pub-id pub-id-type="pmcid">PMC2034723</pub-id></mixed-citation></ref><ref id="zoi250960r18"><label>18</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Asdaghi</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ciliberti-Vargas</surname><given-names>MA</given-names></string-name>, <etal/>; <collab>FL-PR CReSD Investigators and Collaborators</collab></person-group>. <article-title>Predictors of thrombolysis administration in mild stroke: Florida-Puerto Rico Collaboration to Reduce Stroke Disparities</article-title>. <source>Stroke</source>. <year>2018</year>;<volume>49</volume>(<issue>3</issue>):<fpage>638</fpage>-<lpage>645</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.117.019341</pub-id><pub-id pub-id-type="pmid">29459397</pub-id><pub-id pub-id-type="pmcid">PMC5829011</pub-id></mixed-citation></ref><ref id="zoi250960r19"><label>19</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Powers</surname><given-names>WJ</given-names></string-name>, <string-name name-style="western"><surname>Rabinstein</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Ackerson</surname><given-names>T</given-names></string-name>, <etal/>; <collab>American Heart Association Stroke Council</collab></person-group>. <article-title>2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association</article-title>. <source>Stroke</source>. <year>2018</year>;<volume>49</volume>(<issue>3</issue>):<fpage>e46</fpage>-<lpage>e110</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STR.0000000000000158</pub-id><pub-id pub-id-type="pmid">29367334</pub-id></mixed-citation></ref><ref id="zoi250960r20"><label>20</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Kogan</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Twyman</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Heap</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Milentijevic</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Alberts</surname><given-names>M</given-names></string-name></person-group>. <article-title>Assessing stroke severity using electronic health record data: a machine learning approach</article-title>. <source>BMC Med Inform Decis Mak</source>. <year>2020</year>;<volume>20</volume>(<issue>1</issue>):<fpage>8</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12911-019-1010-x</pub-id><pub-id pub-id-type="pmid">31914991</pub-id><pub-id pub-id-type="pmcid">PMC6950922</pub-id></mixed-citation></ref><ref id="zoi250960r21"><label>21</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Lin</surname><given-names>CB</given-names></string-name>, <string-name name-style="western"><surname>Peterson</surname><given-names>ED</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>EE</given-names></string-name>, <etal/></person-group>. <article-title>Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>. <year>2012</year>;<volume>5</volume>(<issue>4</issue>):<fpage>514</fpage>-<lpage>522</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.112.965210</pub-id><pub-id pub-id-type="pmid">22787065</pub-id></mixed-citation></ref><ref id="zoi250960r22"><label>22</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Jahan</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Saver</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Schwamm</surname><given-names>LH</given-names></string-name>, <etal/></person-group>. <article-title>Association between time to treatment with endovascular reperfusion therapy and outcomes in patients with acute ischemic stroke treated in clinical practice</article-title>. <source>JAMA</source>. <year>2019</year>;<volume>322</volume>(<issue>3</issue>):<fpage>252</fpage>-<lpage>263</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2019.8286</pub-id><pub-id pub-id-type="pmid">31310296</pub-id><pub-id pub-id-type="pmcid">PMC6635908</pub-id></mixed-citation></ref><ref id="zoi250960r23"><label>23</label><mixed-citation publication-type="webpage">Stroke certification. Joint Commission. Accessed June 22, 2025. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.jointcommission.org/resources/news-and-multimedia/fact-sheets/facts-about-stroke-certification/" ext-link-type="uri">https://www.jointcommission.org/resources/news-and-multimedia/fact-sheets/facts-about-stroke-certification/</ext-link></mixed-citation></ref><ref id="zoi250960r24"><label>24</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Ali</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Fonarow</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>Rates, characteristics, and outcomes of patients transferred to specialized stroke centers for advanced care</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>. <year>2018</year>;<volume>11</volume>(<issue>9</issue>):<elocation-id>e003359</elocation-id>. doi:<pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.116.003359</pub-id><pub-id pub-id-type="pmid">30354551</pub-id></mixed-citation></ref><ref id="zoi250960r25"><label>25</label><mixed-citation publication-type="webpage">Specifications manual for Joint Commission national quality measures (v2024A1). Joint Commission. <year>2024</year>. Accessed August 5, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://manual.jointcommission.org/releases/TJC2024A1/MIF0391.html" ext-link-type="uri">https://manual.jointcommission.org/releases/TJC2024A1/MIF0391.html</ext-link></mixed-citation></ref><ref id="zoi250960r26"><label>26</label><mixed-citation publication-type="webpage">Door-in-door out best practice strategies. American Heart Association. Accessed December 6, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.heart.org/-/media/Files/Professional/Quality-Improvement/Get-With-the-Guidelines/Get-With-The-Guidelines-Stroke/Uploads-DIDO-08122021/DIDO-Best-Practices_F1.pdf" ext-link-type="uri">https://www.heart.org/-/media/Files/Professional/Quality-Improvement/Get-With-the-Guidelines/Get-With-The-Guidelines-Stroke/Uploads-DIDO-08122021/DIDO-Best-Practices_F1.pdf</ext-link></mixed-citation></ref><ref id="zoi250960r27"><label>27</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Stamm</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Royan</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Giurcanu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Messe</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Jauch</surname><given-names>EC</given-names></string-name>, <string-name name-style="western"><surname>Prabhakaran</surname><given-names>S</given-names></string-name></person-group>. <article-title>Door-in-door-out times for interhospital transfer of patients with stroke</article-title>. <source>JAMA</source>. <year>2023</year>;<volume>330</volume>(<issue>7</issue>):<fpage>636</fpage>-<lpage>649</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2023.12739</pub-id><pub-id pub-id-type="pmid">37581671</pub-id><pub-id pub-id-type="pmcid">PMC10427946</pub-id></mixed-citation></ref><ref id="zoi250960r28"><label>28</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Gadhia</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Schwamm</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Viswanathan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Whitney</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Moreno</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Zachrison</surname><given-names>KS</given-names></string-name></person-group>. <article-title>Evaluation of the experience of spoke hospitals in an academic telestroke network</article-title>. <source>Telemed J E Health</source>. <year>2019</year>;<volume>25</volume>(<issue>7</issue>):<fpage>584</fpage>-<lpage>590</lpage>. doi:<pub-id pub-id-type="doi">10.1089/tmj.2018.0133</pub-id><pub-id pub-id-type="pmid">30256724</pub-id></mixed-citation></ref><ref id="zoi250960r29"><label>29</label><mixed-citation publication-type="webpage">Michigan Stroke Program. Michigan Department of Health &amp; Human Services. Accessed November 20, 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.michigan.gov/mdhhs/keep-mi-healthy/communicablediseases/epidemiology/chronicepi/stroke" ext-link-type="uri">https://www.michigan.gov/mdhhs/keep-mi-healthy/communicablediseases/epidemiology/chronicepi/stroke</ext-link></mixed-citation></ref><ref id="zoi250960r30"><label>30</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Wilcock</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Schwamm</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Zubizarreta</surname><given-names>JR</given-names></string-name>, <etal/></person-group>. <article-title>Reperfusion treatment and stroke outcomes in hospitals with telestroke capacity</article-title>. <source>JAMA Neurol</source>. <year>2021</year>;<volume>78</volume>(<issue>5</issue>):<fpage>527</fpage>-<lpage>535</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamaneurol.2021.0023</pub-id><pub-id pub-id-type="pmid">33646272</pub-id><pub-id pub-id-type="pmcid">PMC7922240</pub-id></mixed-citation></ref><ref id="zoi250960r31"><label>31</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Goyal</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Menon</surname><given-names>BK</given-names></string-name>, <string-name name-style="western"><surname>van Zwam</surname><given-names>WH</given-names></string-name>, <etal/>; <collab>HERMES collaborators</collab></person-group>. <article-title>Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials</article-title>. <source>Lancet</source>. <year>2016</year>;<volume>387</volume>(<issue>10029</issue>):<fpage>1723</fpage>-<lpage>1731</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(16)00163-X</pub-id><pub-id pub-id-type="pmid">26898852</pub-id></mixed-citation></ref><ref id="zoi250960r32"><label>32</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>ElHabr</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Katz</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Predicting 90-day modified Rankin Scale score with discharge information in acute ischaemic stroke patients following treatment</article-title>. <source>BMJ Neurol Open</source>. <year>2021</year>;<volume>3</volume>(<issue>1</issue>):<elocation-id>e000177</elocation-id>. doi:<pub-id pub-id-type="doi">10.1136/bmjno-2021-000177</pub-id><pub-id pub-id-type="pmid">34250487</pub-id><pub-id pub-id-type="pmcid">PMC8231000</pub-id></mixed-citation></ref></ref-list><notes notes-type="supplementary-material" id="note-ZOI250960-1"><supplementary-material id="note-ZOI250960-1-s" position="float" content-type="local-data" orientation="portrait"><label>Supplement 1.</label><caption><p><bold>eTable 1.</bold> Hospital Characteristics Stratified by Telestroke Hospitals (n = 22) vs Nontelestroke Hospitals (n = 20)</p><p><bold>eTable 2.</bold> Multilevel Model of Discharge Destination Being Home by Telestroke Activation Among Those Who Received Thrombolysis (n = 1673)</p><p><bold>eTable 3.</bold> Multilevel Model of Ability to Ambulate Independently at Discharge by Telestroke Activation Among Those Who Received Thrombolysis (n = 1446)</p><p><bold>eTable 4.</bold> Multilevel Model of Door-to-Needle (DTN) Time (&#8804;45 Minutes) by Telestroke Activation, With and Without Adjustment for Patient and Hospital Characteristics (n = 1672)</p><p><bold>eTable 5.</bold> Multilevel Model of Door-in-Door-Out time by Telestroke Activation in Participants Who Were Transferred to Another Hospital</p><p><bold>eTable 6.</bold> Multilevel Model of Receipt of Thrombolysis by Telestroke Activation, With and Without Adjustment for Patient and Hospital Characteristics, Excluding Participants Who Were Transferred</p><p><bold>eTable 7.</bold> Multilevel Model of Door-to-Needle Time by Telestroke Activation, With and Without Adjustment for Patient and Hospital Characteristics, Excluding Patients Who Were Transferred</p><p><bold>eTable 8.</bold> Multilevel Model of Guideline-Concordant Door-to-Needle (DTN) Time (&#8804;60 Minutes) by Telestroke Activation, With or Without Adjustment for Patient and Hospital Characteristics, Excluding Patients Who Were Transferred</p><p><bold>eTable 9.</bold> Baseline Patient and Hospital Characteristics Stratified by Missingness of Telestroke Activation (n = 4259)</p><p><bold>eTable 10.</bold> Multilevel Model of Receipt of Thrombolysis by Telestroke Activation, With and Without Adjustment for Patient and Hospital Characteristics (Participants With Missing Telestroke Activation Are Included as No Telestroke)</p><p><bold>eTable 11.</bold> Multilevel Model of Door-to-Needle (DTN) Time by Telestroke Activation, With and Without Adjustment for Patient and Hospital Characteristics (Participants With Missing Telestroke Activation Are Included as No Telestroke)</p><p><bold>eTable 12.</bold> Multilevel Model of Guideline-Concordant Door-to-Needle (DTN) Time (&#8804;60 Minutes) by Telestroke Activation, With and Without Adjustment for Patient and Hospital Characteristics (Participants With Missing Telestroke Activation Are Included as No Telestroke)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jamanetwopen-e2534275-s001.xlsx" position="float" orientation="portrait"/></supplementary-material><supplementary-material position="float" content-type="local-data" orientation="portrait"><label>Supplement 2.</label><caption><p><bold>eFigure 1.</bold> Study Population</p><p><bold>eFigure 2.</bold> Variation in Telestroke Use at the Hospital Level</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jamanetwopen-e2534275-s002.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material position="float" content-type="local-data" orientation="portrait"><label>Supplement 3.</label><caption><p>
Data Sharing Statement
</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jamanetwopen-e2534275-s003.pdf" position="float" orientation="portrait"/></supplementary-material></notes></back></article></pmc-articleset>